Cover
Cover - shares | 6 Months Ended | |
Jun. 30, 2024 | Jul. 31, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Jun. 30, 2024 | |
Document Transition Report | false | |
Entity File Number | 0-19254 | |
Entity Registrant Name | LIFETIME BRANDS, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 11-2682486 | |
Entity Address, Address Line One | 1000 Stewart Avenue | |
Entity Address, City or Town | Garden City | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 11530 | |
City Area Code | (516) | |
Local Phone Number | 683-6000 | |
Title of 12(b) Security | Common Stock, $.01 par value | |
Trading Symbol | LCUT | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 22,157,912 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q2 | |
Current Fiscal Year End Date | --12-31 | |
Entity Central Index Key | 0000874396 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
CURRENT ASSETS | ||
Cash and cash equivalents | $ 3,396 | $ 16,189 |
Accounts receivable, less allowances of $13,684 at June 30, 2024 and $15,952 at December 31, 2023 | 112,530 | 155,180 |
Inventory | 208,480 | 188,647 |
Prepaid expenses and other current assets | 15,344 | 16,339 |
Income taxes receivable | 3,546 | 0 |
TOTAL CURRENT ASSETS | 343,296 | 376,355 |
PROPERTY AND EQUIPMENT, net | 15,689 | 16,970 |
OPERATING LEASE RIGHT-OF-USE ASSETS | 64,091 | 69,756 |
INVESTMENT | 0 | 1,826 |
INTANGIBLE ASSETS, net | 191,624 | 199,133 |
OTHER ASSETS | 2,264 | 3,102 |
TOTAL ASSETS | 616,964 | 667,142 |
CURRENT LIABILITIES | ||
Current maturity of term loan | 6,822 | 4,742 |
Accounts payable | 59,523 | 54,154 |
Accrued expenses | 64,974 | 78,356 |
Income taxes payable | 0 | 641 |
Current portion of operating lease liabilities | 14,516 | 14,075 |
TOTAL CURRENT LIABILITIES | 145,835 | 151,968 |
OTHER LONG-TERM LIABILITIES | 13,401 | 9,126 |
INCOME TAXES PAYABLE, LONG-TERM | 1,493 | 1,493 |
OPERATING LEASE LIABILITIES | 62,937 | 70,009 |
DEFERRED INCOME TAXES | 7,580 | 7,438 |
REVOLVING CREDIT FACILITY | 32,635 | 60,395 |
TERM LOAN | 133,278 | 135,834 |
STOCKHOLDERS’ EQUITY | ||
Preferred stock, $1.00 par value, shares authorized: 100 shares of Series A and 2,000,000 shares of Series B; none issued and outstanding | 0 | 0 |
Common stock, $0.01 par value, shares authorized: 50,000,000 at June 30, 2024 and December 31, 2023; shares issued and outstanding: 22,157,912 at June 30, 2024 and 21,813,266 at December 31, 2023 | 222 | 218 |
Paid-in capital | 278,484 | 277,728 |
Accumulated deficit | (39,895) | (13,568) |
Accumulated other comprehensive loss | (19,006) | (33,499) |
TOTAL STOCKHOLDERS’ EQUITY | 219,805 | 230,879 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 616,964 | $ 667,142 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Accounts receivable, allowances | $ 13,684 | $ 15,952 |
Common stock, par value (usd per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 50,000,000 | 50,000,000 |
Common stock, shares issued (in shares) | 22,157,912 | 21,813,266 |
Common stock, shares outstanding (in shares) | 22,157,912 | 21,813,266 |
Preferred stock Series A | ||
Preferred stock, par value (usd per share) | $ 1 | $ 1 |
Preferred stock, shares authorized (in shares) | 100 | 100 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Preferred stock Series B | ||
Preferred stock, par value (usd per share) | $ 1 | $ 1 |
Preferred stock, shares authorized (in shares) | 2,000,000 | 2,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Statement [Abstract] | ||||
Net sales | $ 141,666 | $ 146,436 | $ 283,908 | $ 291,871 |
Cost of sales | 87,116 | 90,445 | 171,811 | 182,038 |
Gross margin | 54,550 | 55,991 | 112,097 | 109,833 |
Distribution expenses | 15,052 | 15,732 | 31,233 | 32,617 |
Selling, general and administrative expenses | 38,331 | 35,863 | 77,867 | 73,770 |
Restructuring expenses | 0 | 0 | 0 | 856 |
Income from operations | 1,167 | 4,396 | 2,997 | 2,590 |
Interest expense | (5,157) | (5,528) | (10,771) | (10,864) |
Mark to market (loss) gain on interest rate derivatives | (82) | 197 | (256) | (37) |
Gain on extinguishments of debt, net | 0 | 1,520 | ||
Loss on equity securities | (14,152) | 0 | (14,152) | 0 |
(Loss) income before income taxes and equity in losses | (18,224) | 585 | (22,182) | (6,791) |
Income tax benefit (provision) | 57 | (1,242) | (153) | 106 |
Equity in losses, net of taxes | 0 | (5,863) | (2,092) | (8,640) |
NET LOSS | $ (18,167) | $ (6,520) | $ (24,427) | $ (15,325) |
Basic income (loss) per common share (usd per share) | $ (0.85) | $ (0.31) | $ (1.14) | $ (0.72) |
Diluted income (loss) per common share (usd per share) | $ (0.85) | $ (0.31) | $ (1.14) | $ (0.72) |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Statement of Comprehensive Income [Abstract] | ||||
Net loss | $ (18,167) | $ (6,520) | $ (24,427) | $ (15,325) |
Other comprehensive income, net of taxes: | ||||
Net change in translation adjustment | 14,205 | 1,237 | 14,245 | 2,798 |
Net change in cash flow hedges | 22 | (300) | 223 | (1,453) |
Effect of retirement benefit obligations | 12 | 11 | 25 | 23 |
Other comprehensive income, net of taxes | 14,239 | 948 | 14,493 | 1,368 |
Comprehensive loss | $ (3,928) | $ (5,572) | $ (9,934) | $ (13,957) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Common stock | Common stock Employee [Member] | Paid-in capital | Paid-in capital Employee [Member] | Retained earnings (accumulated deficit) | Accumulated other comprehensive loss | ||
Beginning Balance (in shares) at Dec. 31, 2022 | 21,780 | ||||||||
Balance at beginning of year at Dec. 31, 2022 | $ 240,088 | $ 218 | $ 274,579 | $ 1,145 | $ (35,854) | ||||
Comprehensive (loss) income: | |||||||||
Net loss | (8,805) | (8,805) | |||||||
Other Comprehensive Income (Loss), Net of Tax | 420 | 420 | |||||||
Performance shares issued to employees (in shares) | 120 | ||||||||
Performance shares issued to employees | $ 1 | $ (1) | |||||||
Net issuance of restricted shares to employees and directors (in shares) | 185 | ||||||||
Net issuance of restricted shares granted to employees | $ 2 | (2) | |||||||
Stock compensation expense | 866 | 866 | |||||||
Shares effectively repurchased for required employee withholding taxes (in shares) | (74) | ||||||||
Shares effectively repurchased for required employee withholding taxes | (439) | $ (1) | (438) | ||||||
Treasury Stock, Shares, Acquired | 320 | ||||||||
Stock Repurchased During Period, Value | 2,539 | $ 3 | 0 | 2,536 | |||||
Dividends | (930) | (930) | |||||||
Ending Balance (in shares) at Mar. 31, 2023 | 21,691 | ||||||||
Balance at end of year at Mar. 31, 2023 | 228,661 | [1] | $ 217 | 275,004 | (11,126) | [1] | (35,434) | ||
Beginning Balance (in shares) at Dec. 31, 2022 | 21,780 | ||||||||
Balance at beginning of year at Dec. 31, 2022 | 240,088 | $ 218 | 274,579 | 1,145 | (35,854) | ||||
Comprehensive (loss) income: | |||||||||
Net loss | (15,325) | ||||||||
Other Comprehensive Income (Loss), Net of Tax | 1,368 | ||||||||
Ending Balance (in shares) at Jun. 30, 2023 | 21,814 | ||||||||
Balance at end of year at Jun. 30, 2023 | (223,051) | [1] | $ 218 | 275,915 | (18,596) | [1] | (34,486) | ||
Beginning Balance (in shares) at Mar. 31, 2023 | 21,691 | ||||||||
Balance at beginning of year at Mar. 31, 2023 | 228,661 | [1] | $ 217 | 275,004 | (11,126) | [1] | (35,434) | ||
Comprehensive (loss) income: | |||||||||
Net loss | (6,520) | (6,520) | |||||||
Other Comprehensive Income (Loss), Net of Tax | 948 | 948 | |||||||
Net issuance of restricted shares to employees and directors (in shares) | 141 | ||||||||
Net issuance of restricted shares granted to employees | $ 1 | (1) | |||||||
Stock compensation expense | 1,010 | 1,010 | |||||||
Shares effectively repurchased for required employee withholding taxes (in shares) | (18) | ||||||||
Shares effectively repurchased for required employee withholding taxes | (98) | $ 0 | (98) | ||||||
Dividends | (950) | (950) | |||||||
Ending Balance (in shares) at Jun. 30, 2023 | 21,814 | ||||||||
Balance at end of year at Jun. 30, 2023 | (223,051) | [1] | $ 218 | 275,915 | (18,596) | [1] | (34,486) | ||
Beginning Balance (in shares) at Dec. 31, 2023 | 21,813 | ||||||||
Balance at beginning of year at Dec. 31, 2023 | 230,879 | $ 218 | 277,728 | (13,568) | (33,499) | ||||
Comprehensive (loss) income: | |||||||||
Net loss | (6,260) | (6,260) | |||||||
Other Comprehensive Income (Loss), Net of Tax | 254 | 254 | |||||||
Performance shares issued to employees (in shares) | 152 | ||||||||
Performance shares issued to employees | $ 2 | (2) | |||||||
Net issuance of restricted shares to employees and directors (in shares) | 213 | ||||||||
Net issuance of restricted shares granted to employees | $ 2 | (2) | |||||||
Stock compensation expense | 799 | 799 | |||||||
Shares effectively repurchased for required employee withholding taxes (in shares) | (105) | ||||||||
Shares effectively repurchased for required employee withholding taxes | (1,028) | $ (1) | (1,027) | ||||||
Dividends | (943) | (943) | |||||||
Ending Balance (in shares) at Mar. 31, 2024 | 22,073 | ||||||||
Balance at end of year at Mar. 31, 2024 | 223,701 | $ 221 | 277,496 | (20,771) | (33,245) | ||||
Beginning Balance (in shares) at Dec. 31, 2023 | 21,813 | ||||||||
Balance at beginning of year at Dec. 31, 2023 | 230,879 | $ 218 | 277,728 | (13,568) | (33,499) | ||||
Comprehensive (loss) income: | |||||||||
Net loss | (24,427) | ||||||||
Other Comprehensive Income (Loss), Net of Tax | 14,493 | ||||||||
Ending Balance (in shares) at Jun. 30, 2024 | 22,158 | ||||||||
Balance at end of year at Jun. 30, 2024 | 219,805 | $ 222 | 278,484 | (39,895) | (19,006) | ||||
Beginning Balance (in shares) at Mar. 31, 2024 | 22,073 | ||||||||
Balance at beginning of year at Mar. 31, 2024 | 223,701 | $ 221 | 277,496 | (20,771) | (33,245) | ||||
Comprehensive (loss) income: | |||||||||
Net loss | (18,167) | (18,167) | |||||||
Other Comprehensive Income (Loss), Net of Tax | 14,239 | 14,239 | |||||||
Net issuance of restricted shares to employees and directors (in shares) | 92 | ||||||||
Net issuance of restricted shares granted to employees | $ 1 | $ (1) | |||||||
Stock compensation expense | 1,044 | 1,044 | |||||||
Shares effectively repurchased for required employee withholding taxes (in shares) | (7) | ||||||||
Shares effectively repurchased for required employee withholding taxes | (55) | $ 0 | (55) | ||||||
Dividends | (957) | (957) | |||||||
Ending Balance (in shares) at Jun. 30, 2024 | 22,158 | ||||||||
Balance at end of year at Jun. 30, 2024 | $ 219,805 | $ 222 | $ 278,484 | $ (39,895) | $ (19,006) | ||||
[1] Cash dividends declared per share of common stock were $0.085 and $0.085 in the six months ended June 30, 2024 and 2023, respectively. |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares | 6 Months Ended | |||
Jun. 20, 2024 | Mar. 08, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | |
Statement of Stockholders' Equity [Abstract] | ||||
Dividend per share of common stock (usd per share) | $ 0.0425 | $ 0.0425 | $ 0.085 | $ 0.085 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
OPERATING ACTIVITIES | ||
Net loss | $ (24,427) | $ (15,325) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Depreciation and amortization | 9,833 | 9,795 |
Amortization of financing costs | 1,471 | 975 |
Mark to market loss on interest rate derivatives | 256 | 37 |
Non-cash lease adjustment | (965) | (1,255) |
(Recovery) provision for doubtful accounts | (287) | 1,528 |
Deferred income taxes | 144 | 0 |
Stock compensation expense | 1,844 | 1,872 |
Equity in losses, net of taxes | 2,092 | 8,640 |
Gain on extinguishments of debt, net | 0 | 1,520 |
Debt and Equity Securities, Gain (Loss) | 14,152 | 0 |
Changes in operating assets and liabilities | ||
Accounts receivable | 42,712 | 25,524 |
Inventory | (20,184) | 11,492 |
Prepaid expenses, other current assets and other assets | 1,687 | 1,563 |
Accounts payable, accrued expenses and other liabilities | (3,213) | (10,989) |
Income taxes receivable | (3,546) | (3,049) |
Income taxes payable | (639) | (245) |
NET CASH PROVIDED BY OPERATING ACTIVITIES | 20,930 | 28,993 |
INVESTING ACTIVITIES | ||
Purchases of property and equipment | (1,098) | (993) |
NET CASH USED IN INVESTING ACTIVITIES | (1,098) | (993) |
FINANCING ACTIVITIES | ||
Payments of Financing Costs | 0 | 433 |
Payments for finance lease obligations | (14) | (14) |
Payments of tax withholding for stock based compensation | (1,083) | (537) |
Payments for stock repurchase | 0 | (2,539) |
Cash dividends paid | (1,977) | (1,907) |
NET CASH USED IN FINANCING ACTIVITIES | (32,546) | (36,464) |
Effect of foreign exchange on cash | (79) | (12) |
DECREASE IN CASH AND CASH EQUIVALENTS | (12,793) | (8,476) |
Cash and cash equivalents at beginning of period | 16,189 | 23,598 |
CASH AND CASH EQUIVALENTS AT END OF PERIOD | 3,396 | 15,122 |
S'well [Member] | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Contingent consideration fair value adjustments | 0 | (50) |
Revolving Credit Facility | ||
FINANCING ACTIVITIES | ||
Proceeds from revolving credit facility | 74,207 | 30,378 |
Repayments of Long-Term Lines of Credit | (101,804) | (16,546) |
Term Loan | ||
Adjustments to reconcile net loss to net cash provided by operating activities: | ||
Gain on extinguishments of debt, net | 0 | (1,520) |
FINANCING ACTIVITIES | ||
Repayments of Long-Term Lines of Credit | $ (1,875) | $ (44,866) |
BASIS OF PRESENTATION AND SUMMA
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES | BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES Organization and business Lifetime Brands, Inc. (“the Company”) designs, sources and sells branded kitchenware, tableware and other products used in the home and markets its products under a number of widely-recognized brand names and trademarks, which are either owned or licensed by the Company or through retailers’ private labels and their licensed brands. The Company’s products, which are targeted primarily towards consumers purchasing moderately priced kitchenware, tableware and housewares, are sold through virtually every major level of trade. The Company generally markets several lines within each of its product categories under more than one brand. The Company sells its products directly to retailers (who may resell the Company’s products through their websites) and, to a lesser extent, to distributors. The Company also sells a limited selection of its products directly to consumers through its own websites. Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist of normal recurring accruals and non-recurring adjustments, considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Operating results for the three and six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. The Company’s business and working capital needs are seasonal, with a majority of sales occurring in the third and fourth quarters. In 2023 and 2022, net sales for the third and fourth quarters accounted for 57% and 54% of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period. The Company’s current estimates contemplate current and expected future conditions, as applicable, however it is reasonably possible that actual conditions could differ from expectations, which could materially affect the Company’s results of operations and financial position. Revenue recognition The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are primarily recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and an estimate for products expected to be returned are reflected as reductions of revenue at the time of sale. See NOTE 2 —REVENUE to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information. Cost of sales Cost of sales consist primarily of costs associated with the production and procurement of product, inbound freight costs, purchasing costs, royalties, and other product procurement related charges. Distribution expenses Distribution expenses consist primarily of warehousing expenses and freight-out expenses. Handling costs of products sold are included in cost of sales. Accounts receivable The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated credit losses that could result from the inability of its customers to make required payments, taking into consideration customer credit history and financial condition, industry and market segment information, credit reports, and expectations of current and future economic conditions. A considerable amount of judgment is required to assess the ultimate realization of these receivables, including assessing the initial and on-going creditworthiness of the Company’s customers. The Company also maintains an allowance for anticipated customer deductions. The allowances for deductions are primarily based on contracts with customers. However, in certain cases, the Company does not have a formal contract and, therefore, customer deductions are non-contractual. To evaluate the reasonableness of non-contractual customer deductions, the Company analyzes currently available information and historical trends of deductions. Receivable purchase agreement The Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company’s unaudited condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company’s unaudited condensed consolidated statements of operations. The Company did not sell receivables to HSBC during the three and six months ended June 30, 2024 and June 30, 2023. At June 30, 2024, $18.7 million of accounts receivables were available for sale to HSBC, net of applicable charges. Inventory Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company’s manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product-by-product basis based on the current selling environment. If the estimated selling price is lower than the inventory’s cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. The components of inventory were as follows (in thousands): June 30, December 31, 2023 Finished goods $ 198,776 $ 180,860 Work in process 28 106 Raw materials 9,676 7,681 Total $ 208,480 $ 188,647 Fair value of financial instruments The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its ABL Agreement and Term Loan (each as defined in NOTE 6 — DEBT to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q) approximate fair value since such borrowings bear interest at variable market rates. Derivatives The Company accounts for derivative instruments in accordance with Accounting Standard Codification (“ASC”) Topic 815, Derivatives and Hedging ( “ASC 815” ) . ASC 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes have no net impact on earnings until the hedged item is recognized in earnings. The changes in the fair value of hedges are included in accumulated other comprehensive loss and are subsequently recognized in the Company’s unaudited condensed consolidated statements of operations to mirror the location of the hedged items impacting earnings. Changes in fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company’s unaudited condensed consolidated statements of operations. Goodwill, intangible assets and long-lived assets Goodwill and intangible assets deemed to have indefinite lives are not amortized but, instead, are subject to an annual impairment assessment. Additionally, if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable, the Company would evaluate goodwill and other intangible assets for impairment at that time. As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative goodwill impairment testing described in the Financial Accounting Standards Board's (“FASB”) Accounting Standards Update No. (“ASU”) Topic 350, Intangibles – Goodwill and Other. If, after assessing qualitative factors, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the quantitative test is unnecessary and the Company’s goodwill is considered to be unimpaired. However, if based on the Company’s qualitative assessment it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test. The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of October 1 or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values. Impairment testing is based upon the best information available, including estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. The Company performed its annual impairment assessment of its U.S. reporting unit as of October 1, 2023 by comparing the fair value of the reporting unit with its carrying value. The Company performed the analysis using a discounted cash flow and market multiple method. As of October 1, 2023, the fair value of the U.S. reporting unit exceeded the carrying value of goodwill by 4%. The significant assumptions used under the income approach, or discounted cash flow method, are projected net sales, projected earnings before interest, tax, depreciation and amortization (“EBITDA”) and the cost of capital. Projected net sales and projected EBITDA were determined to be significant assumptions because they are the primary drivers of the projected cash flows in the discounted cash flow fair value model. Cost of capital was also determined to be a significant assumption as it is the discount rate used to calculate the current fair value of those projected cash flows. Although the Company believes the assumptions and estimates made are reasonable and appropriate, different assumptions and estimates could materially impact its reported financial results. In addition, sustained declines in the Company’s stock price and related market capitalization could impact key assumptions in the overall estimated fair values of its reporting units and could result in non-cash impairment charges that could be material to the Company’s consolidated balance sheet or results of operations. Should the carrying value of a reporting unit be in excess of the estimated fair value of that reporting unit, an impairment charge will be recorded to reduce the reporting unit to fair value. The Company also evaluates qualitative factors to determine whether impairment indicators exist for its indefinite-lived intangibles and performs quantitative tests if required. These tests can include the relief from royalty model or other valuation models. The significant assumptions used in the relief from royalty model are future net sales for the related brands, royalty rates and the cost of capital to determine the fair value of the indefinite-lived intangibles. The Company completed the quantitative impairment analysis for its indefinite-lived asset as of October 1, 2023, by comparing the fair value of the indefinite-lived trade name to the carrying value using a relief from royalty method. As of October 1, 2023, the fair value of the Company’s indefinite-lived trade name exceeded its carrying value by 7%. While the indefinite-lived trade name was not determined to be impaired, if the indefinite-lived trade name does not perform as projected or if market factors utilized in the impairment analysis deteriorate, including an unfavorable change in the weighted average cost of capital, could materially affect the expected cash flows, and such impacts could potentially result in a material non-cash impairment charge. Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset is not recoverable, the impairment to be recognized is measured by the amount by which the carrying amount of each long-lived asset exceeds the fair value of the asset. See NOTE 5 — INTANGIBLE ASSETS to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information. Leases The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other long-term liabilities. The Company’s finance leases are not material to the Company’s condensed consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. Employee healthcare The Company self-insures certain portions of its health insurance plan. The Company maintains an accrual for estimated unpaid claims and claims incurred but not yet reported (“IBNR”). Although management believes that it uses the best information available to estimate IBNR claims, actual claims may vary significantly from estimated claims. Restructuring expenses Costs associated with restructuring activities are recorded at fair value when a liability has been incurred. Generally, a liability has been incurred at the communication date for severance. Charges associated with lease terminations, related to restructuring activities, are recognized at the effective date of the lease modification. During the six months ended June 30, 2023, the Company incurred $0.8 million of unallocated corporate expense related to the termination payment with its former Executive Chairman, Jeffrey Siegel (the “Executive Chairman”). On November 1, 2022, the Company entered into a transition agreement with its Executive Chairman which terminated his employment with the Company, effective March 31, 2023. The employment agreement provided for a one-time payment, which was paid on April 7, 2023. New accounting pronouncements Updates not listed below were assessed and either determined to not be applicable or are expected to have a minimal effect on the Company’s financial position, results of operations, and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures: which enhances the disclosures required for operating segments in the Company’s annual and interim consolidated financial statements. The new guidance is effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures: This guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. The new guidance is effective for public business entities for annual periods beginning after December 15, 2024 on a prospective basis. Retrospective application is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. |
REVENUE
REVENUE | 6 Months Ended |
Jun. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
REVENUE | REVENUE The Company sells products wholesale, to retailers and distributors, and sells products retail, directly to consumers. Wholesale sales and retail sales are recognized at the point in time the customer obtains control of the products in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. To indicate the transfer of control, the Company must have a present right to payment, legal title must have passed to the customer, the customer must have the significant risks and rewards of ownership, and where acceptance is not a formality, the customer must have accepted the product or service. The Company’s principal terms of sale are Free On Board (“FOB”) Shipping Point, or equivalent, and, as such, the Company primarily transfers control and records revenue for product sales upon shipment. Sales arrangements with delivery terms that are not FOB Shipping Point are not recognized upon shipment and the transfer of control for revenue recognition is evaluated based on the associated shipping terms and customer obligations. Shipping and handling fees that are billed to customers in sales transactions are included in net sales and amounted to $0.6 million and $1.2 million for the three and six months ended June 30, 2024, respectively and $0.5 million and $0.9 million for the three and six months ended June 30, 2023, respectively. Net sales exclude taxes that are collected from customers and remitted to the taxing authorities. The Company offers various sales incentives and promotional programs to its wholesale customers from time to time in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These sales incentives and promotions represent variable consideration and are reflected as reductions in net sales in the Company’s unaudited condensed consolidated statements of operations. While many of the sales incentives and promotions are contractually agreed upon with the Company’s customers, certain of the sales incentives and promotions are non-contractual and require the Company to estimate the amount of variable consideration based on historical experience and other known factors or as the most likely amount in a range of possible outcomes. On a quarterly basis, variable consideration is assessed on a portfolio approach in estimating the extent to which the components of variable consideration are constrained. Payment terms vary by customer, but generally range from 30 to 90 days or at the point of sale for the Company’s retail direct sale s. The Company incurs certain direct incremental costs to obtain contracts with customers, such as sales-related co mmissions, where the recognition period for the related revenue is less than one year. These costs are expensed as incurred and recorded within selling, general and administrative expenses in the unaudited condensed consolidated statements of operations. Incidental items that are immaterial in the context of the contract are expensed as incurred. The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three and six months ended June 30, 2024 and 2023 (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 U.S. segment Kitchenware $ 80,787 $ 84,015 $ 164,317 $ 169,747 Tableware 26,341 26,149 52,100 50,148 Home Solutions 23,375 24,815 44,566 48,569 Total U.S. segment 130,503 134,979 260,983 268,464 International segment 11,163 11,457 22,925 23,407 Total net sales $ 141,666 $ 146,436 $ 283,908 $ 291,871 United States $ 118,954 $ 127,295 $ 239,457 $ 254,541 United Kingdom 7,150 7,679 14,616 16,291 Rest of World 15,562 11,462 29,835 21,039 Total net sales $ 141,666 $ 146,436 $ 283,908 $ 291,871 |
LEASES
LEASES | 6 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
LEASES | LEASES The Company has operating leases for corporate offices, distribution facilities, a manufacturing plant, and certain vehicles. The components of lease expense for the three and six months ended June 30, 2024 and 2023 were as follows (in thousands): Three Months Ended June 30, Six Months Ended 2024 2023 2024 2023 Operating lease expenses (1) : Fixed lease expense $ 4,265 $ 4,232 $ 8,528 $ 8,406 Variable lease expense 1,650 1,324 3,018 2,750 Total $ 5,915 $ 5,556 $ 11,546 $ 11,156 (1) Expenses are recorded within distribution expenses and selling, general and administrative expenses on the unaudited condensed consolidated statement of operations. Supplemental cash flow information for lease related liabilities and assets for the six months ended June 30, 2024 and 2023 were as follows (in thousands): Six Months Ended 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 9,493 $ 9,661 Six Months Ended 2024 2023 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 423 $ 2,715 The aggregate future lease payments for operating leases as of June 30, 2024 were as follows (in thousands): Operating 2024 (excluding the six months ended June 30, 2024) $ 9,536 2025 18,888 2026 18,511 2027 14,290 2028 12,830 2029 6,682 Thereafter 11,762 Total lease payments 92,499 Less: Interest (15,046) Present value of lease payments $ 77,453 Average lease terms and discount rates were as follows: June 30, 2024 Operating leases: Weighted-average remaining lease term (years) 5.6 Weighted-average discount rate 6.4 % |
INVESTMENTS
INVESTMENTS | 6 Months Ended |
Jun. 30, 2024 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Investment | INVESTMENT As of June 30, 2024, the Company owned 24.7% of the outstanding capital stock of Grupo Vasconia S.A.B. (“Vasconia”), an integrated manufacturer of aluminum products and a housewares company in Mexico. Shares of Vasconia’s capital stock are traded on the Bolsa Mexicana de Valores, the Mexican Stock Exchange. The Quotation Key is VASCONI. During the second quarter of 2024, Vasconia’s shareholders’ approved a resolution to a reorganization process in terms of the Law of Commercial Bankruptcy in Mexico and subsequently a bankruptcy suit was filed against Vasconia by one of its largest suppliers. The Company concluded that the recent events constituted a loss of significant influence and resulted in the discontinuation of the equity method of accounting. The Company will account for its Vasconia investment at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 321: Investments — Equity Securities , with any changes in fair value recorded within income (loss) on equity securities on the consolidated statements of operations. As a result of the loss of significant influence, the accumulated other comprehensive losses previously recognized under the equity method of accounting was reclassified to the carrying value of the Vasconia investment and subsequently resulted in a non-cash loss of $14.2 million to reduce the investment to its fair value. The fair value of the Vasconia investment was not material as of June 30, 2024. Given Vasconia's limited trading activity, recent operating results of Vasconia and impact of the bankruptcy related activity, the fair value of the Vasconia investment was measured using the income approach based on Level 3 unobservable inputs. Prior to accounting for the investment in Vasconia at fair value, equity in losses, net of taxes recognized for the six months ended June 30, 2024 and the three and six months ended June 30, 2023, included the following: Three Months Ended Six Months Ended 2024 2023 2024 2023 Vasconia equity in losses, net of taxes $ — $ (1,422) $ (2,092) $ (2,146) Impairment on investment in Vasconia — (4,441) — (6,494) Equity in losses, net of taxes $ — $ (5,863) $ (2,092) $ (8,640) |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 6 Months Ended |
Jun. 30, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS | INTANGIBLE ASSETS Intangible assets consisted of the following as of June 30, 2024 and December 31, 2023 (in thousands): June 30, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Goodwill (1) $ 33,237 $ — $ 33,237 $ 33,237 $ — $ 33,237 Indefinite-lived intangible assets: Trade names (1) 42,000 — 42,000 42,000 — 42,000 Finite-lived intangible assets: Licenses 15,847 (12,337) 3,510 15,847 (12,110) 3,737 Trade names (2) 62,478 (25,926) 36,552 62,493 (23,862) 38,631 Customer relationships (2) 143,157 (68,585) 74,572 143,158 (63,630) 79,528 Other (2) 5,871 (4,118) 1,753 5,872 (3,872) 2,000 Total $ 302,590 $ (110,966) $ 191,624 $ 302,607 $ (103,474) $ 199,133 (1) The gross and net value at June 30, 2024 and December 31, 2023 reflect a reduction of $91.7 million in impairment charges on goodwill and $1.0 million in impairment charges on indefinite-lived intangible assets. (2) The gross value and accumulated amortization at June 30, 2024 and December 31, 2023 reflect a reduction of $44.1 million and $(29.3) million, respectively, for the net $14.8 million previous impairment charge on finite-lived intangible assets within the international segment and a $6.5 million reduction in gross value for previous impairment charges on finite-lived intangible assets within the U.S. segment. |
DEBT
DEBT | 6 Months Ended |
Jun. 30, 2024 | |
Debt Disclosure [Abstract] | |
DEBT | DEBT On August 26, 2022, the Company entered into Amendment No. 2 (the “Amendment”) to the Company’s credit agreement, dated as of March 2, 2018 (as amended, the “ABL Agreement”) among the Company, as a Borrower, certain subsidiaries of the Company, as Borrowers and/or Loan Parties, JPMorgan Chase Bank, N.A., as Administrative Agent and a Lender. The ABL Agreement provides for a senior secured asset-based revolving credit facility in the maximum aggregate principal amount of $200.0 million, which facility will mature on August 26, 2027. On November 14, 2023, the Company entered into Amendment No. 2 to amend the Loan Agreement, dated as of March 2, 2018, among the Company, as borrower, the other loan parties from time to time party thereto, the lenders from time to time party thereto, and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, the “Term Loan” and together with the ABL Agreement, the “Debt Agreements”). The Term Loan has a principal amount of $150.0 million, and matures on August 26, 2027. The Term Loan requires the Company to make quarterly payments of principal each equal to 1.25% of the aggregate principal amount of the Term Loan, commencing on March 31, 2024, with the remaining balance payable on the maturity date. The Term Loan requires the Company to make an annual prepayment of principal, beginning with those for the fiscal year ending December 31, 2024, based upon a percentage of the Company’s excess cash flow, (“Excess Cash Flow”), if any. The percentage applied to the Company’s Excess Cash Flow is based on the Company’s Total Net Leverage Ratio (as defined in the Debt Agreements). When an Excess Cash Flow payment is required, each lender has the option to decline a portion or all of the prepayment amount payable to it. Per the Term Loan, when the Company makes an Excess Cash Flow prepayment, the payment is first applied to satisfy the next eight (8) scheduled future quarterly required payments of the Term Loan in order of maturity and then to the remaining scheduled installments on a pro rata basis. The maximum borrowing amount under the ABL Agreement may be increased to up to $250.0 million if certain conditions are met. One or more tranches of additional term loans (the “Incremental Term Facilities”) may be added under the Term Loan if certain conditions are met. The Incremental Facilities may not exceed the sum of (i) $50.0 million plus (ii) an unlimited amount so long as, in the case of (ii) only, the Company’s secured net leverage ratio, as defined in and computed on a pro forma basis pursuant to the Term Loan, after giving effect to such increase, is no greater than 3.25 to 1.00, subject to certain limitations and for the period defined pursuant to the Term Loan but not to mature earlier than the maturity date of the then existing term loans. As of June 30, 2024 and December 31, 2023, the total availability under the ABL Agreement were as follows (in thousands): June 30, 2024 December 31, 2023 Maximum aggregate principal allowed $ 176,700 $ 181,919 Outstanding borrowings under the ABL Agreement (32,635) (60,395) Standby letters of credit (8,534) (2,894) Total availability under the ABL Agreement $ 135,531 $ 118,630 Availability under the ABL Agreement is limited to the lesser of the $200.0 million commitment thereunder and the borrowing base and therefore depends on the valuation of certain current assets comprising the borrowing base. The borrowing capacity under the ABL Agreement will depend, in part, on eligible levels of accounts receivable and inventory that fluctuate regularly. Due to the seasonality of the Company’s business, the Company may have greater borrowing availability during the third and fourth quarters of each year. Consequently, the $200.0 million commitment thereunder may not represent actual borrowing capacity. The Company’s borrowing capacity may be further limited by the Term Loan financial covenant of 5.00 to 1.00 maximum Total Net Leverage Ratio. As of June 30, 2024, the availability under the ABL Agreement, limited by the Term Loan financial covenant, was $97.2 million. The current and non-current portions of the Company’s Term Loan included in the condensed consolidated balance sheets were as follows (in thousands): June 30, 2024 December 31, 2023 Current portion of Term Loan: Term Loan payment $ 7,500 $ 7,500 Estimated Excess Cash Flow principal payment 2,000 — Estimated unamortized debt issuance costs (2,678) (2,758) Total Current portion of Term Loan $ 6,822 $ 4,742 Non-current portion of Term Loan: Term Loan, net of current portion $ 138,625 $ 142,500 Estimated unamortized debt issuance costs (5,347) (6,666) Total Non-current portion of Term Loan $ 133,278 $ 135,834 The estimated Excess Cash Flow principal payment recorded at June 30, 2024 represents the Company’s estimate for the Excess Cash Flow Payment due in 2025. There was no Excess Cash Flow payment due in 2024. The Company’s payment obligations under its Debt Agreements are unconditionally guaranteed by its existing and future U.S. subsidiaries with certain minor exceptions. Certain payment obligations under the ABL Agreement are also direct obligations of its foreign subsidiary borrowers designated as such under the ABL Agreement and, subject to limitations on such guaranty, are guaranteed by the foreign subsidiary borrowers, as well as by the Company. The obligations of the foreign subsidiary borrowers under the ABL Agreement are secured by security interests in substantially all of the assets of, and stock in, such foreign subsidiary borrowers, subject to certain limitations. The obligations of the Company under the Debt Agreements and any hedging arrangements and cash management services and the guarantees by its domestic subsidiaries in respect of those obligations are secured by security interests in substantially all of the assets and stock (but in the case of foreign subsidiaries, limited to 65% of the capital stock in first-tier foreign subsidiaries and not including the stock of subsidiaries of such first-tier foreign subsidiaries) owned by the Company and the U.S. subsidiary guarantors, subject to certain exceptions. Such security interests consist of (1) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the “ABL Collateral”) pledged as collateral in favor of lenders under the ABL Agreement and a second-priority lien in the ABL Collateral in favor of the lenders under the Term Loan and (2) a first-priority lien, subject to certain permitted liens, with respect to certain assets of the Company and certain of its subsidiaries (the “Term Loan Collateral”) pledged as collateral in favor of lenders under the Term Loan and a second-priority lien in the Term Loan Collateral in favor of the lenders under the ABL Agreement. Borrowings under the revolving credit facility bear interest, at the Company’s option, at one of the following rates: (i) an alternate base rate, defined, for any day, as the greater of the prime rate, a federal funds and overnight bank funding based rate plus 0.5% or one-month Adjusted Term Secured Overnight Financing Rate (“SOFR”) plus 1.0% as of a specified date in advance of the determination, but in each case not less than 1.0%, plus a margin of 0.25% to 0.50%, or (ii) Adjusted Term SOFR, which is the Term SOFR Rate for the selected 1, 3 or 6 month interest period plus 0.10% (or Euro Interbank Offered Rate “EURIBOR” for borrowings denominated in Euro; or Sterling Overnight Index Average “SONIA” for borrowings denominated in Pounds Sterling), but in each case not less than zero, plus a margin of 1.25% to 1.50%. The respective margins are based upon average quarterly availability, as defined in and computed pursuant to the ABL Agreement. In addition, the Company pays a commitment fee of 0.20% to 0.25% per annum based on the average daily unused portion of the aggregate commitment under the ABL Agreement. The interest rate on outstanding borrowings under the ABL Agreement at June 30, 2024 was between 4.91% and 8.75%. The Company paid a commitment fee of 0.25% on the unused portion of the ABL Agreement during the six months ended June 30, 2024. The Term Loan bears interest, at the Company’s option, at one of the following rates: (i) alternate base rate, defined, for any day, as the greater of (x) the prime rate, (y) a federal funds and overnight bank funding based rate plus 0.5% or (z) one-month Adjusted Term SOFR, but not less than 1.0%, plus 1.0%, plus a margin of 4.5% or (ii) Adjusted Term SOFR (Term SOFR plus the Term SOFR Adjustment) for the applicable interest period, but not less than 1.0%, plus a margin of 5.5%. The interest rate on outstanding borrowings under the Term Loan at June 30, 2024 was 10.94%. The Debt Agreements provide for customary restrictions and events of default. Restrictions include limitations on additional indebtedness, liens, acquisitions, investments and payment of dividends, among other things. Under the Term Loan, the Total Net Leverage Ratio is not permitted to be greater than 5.00 to 1.00 determined as of the end of each fiscal quarters. Further, the ABL Agreement provides that during any period (a) commencing on the last day of the most recently ended four consecutive fiscal quarters on or prior to the date availability under the ABL Agreement is less than the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement at any time and (b) ending on the day after such availability has exceeded the greater of $20.0 million and 10% of the aggregate commitment under the ABL Agreement for 45 consecutive days, the Company is required to maintain a minimum fixed charge coverage ratio of 1.10 to 1.00 as of the last day of any period of four consecutive fiscal quarters. The Company was in compliance with the covenants of the Debt Agreements at June 30, 2024. On June 8, 2023, the Company completed the repurchase of $47.2 million in principal amount of the Term Loan, for $95 per $100 of principal. The repurchase was executed by way of a reverse Dutch auction, pursuant to and in accordance with the terms and conditions provided for in the Term Loan. In connection therewith, debt issuance costs of $0.5 million were written off and fees of $0.4 million were incurred. The gain on the early retirement of the Term Loan of $1.5 million, net of fees and expenses, was recognized during the three and six months ended June 30, 2023. |
DERIVATIVES
DERIVATIVES | 6 Months Ended |
Jun. 30, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVES | DERIVATIVES Interest Rate Swap Agreements In June 2019 the Company entered into interest rate swap agreements, with an aggregate notional value of $25.0 million and expire in February 2025. In March 2024, the Company entered into a new interest rate swap agreement, with an aggregate notional value of $25.0 million and expire in August 2027. These non-designated interest rate swaps serve as cash flow hedges of the Company’s exposure to the variability of the payment of interest on a portion of its Term Loan borrowings. The Company’s total outstanding notional value of interest rate swaps was $50.0 million at June 30, 2024. The Company’s interest rate swaps that were designated as cash flow hedges of the Company’s exposure to the variability of the payment of interest on a portion of its Term Loan borrowings expired in March 2023. The Company has no designated interest rate swaps at June 30, 2024. Foreign Exchange Contracts The Company is party from time to time to certain foreign exchange contracts, primarily to offset the earnings impact related to fluctuations in foreign currency exchange rates associated with inventory purchases denominated in foreign currencies. Fluctuations in the value of certain foreign currencies as compared to the USD may positively or negatively affect the Company’s revenues, gross margins, operating expenses, and retained earnings, all of which are expressed in USD. Where the Company deems it prudent, the Company engages in hedging programs using foreign currency forward contracts aimed at limiting the impact of foreign currency exchange rate fluctuations on earnings. The Company purchases foreign currency forward contracts with terms less than 18 months to protect against currency exchange risks associated with the payment of merchandise purchases to foreign suppliers. The Company does not hedge the translation of foreign currency profits into USD, as the Company regards this as an accounting exposure rather than an economic exposure. The aggregate gross notional value of foreign exchange contracts at June 30, 2024 was $5.2 million. These foreign exchange contracts have been designated as hedges in order to apply hedge accounting. The Company is exposed to market risks as well as changes in foreign currency exchange rates as measured against the USD and each other, and to changes to the credit risk of derivative counterparties. The Company attempts to minimize these risks primarily by using foreign currency forward contracts and by maintaining counterparty credit limits. These hedging activities provide only limited protection against currency exchange and credit risk. Factors that could influence the effectiveness of the Company’s hedging programs include those impacting currency markets and the availability of hedging instruments and liquidity of the credit markets. All foreign currency forward contracts that the Company enters into are components of hedging programs and are entered into for the sole purpose of hedging an existing or anticipated currency exposure. The Company does not enter into such contracts for speculative purposes, and as of June 30, 2024, these foreign exchange contracts have been designated as hedges in to order to apply hedge accounting. The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands): Derivatives designated as hedging instruments Balance Sheet Location June 30, 2024 December 31, 2023 Foreign exchange contracts Prepaid expenses and other current assets $ 44 $ 56 Accrued expenses 53 144 Derivatives not designated as hedging instruments Balance Sheet Location June 30, 2024 December 31, 2023 Interest rate swaps Prepaid expenses and other current assets $ 553 $ — Other assets — 793 Other long-term liabilities 16 — The fair values of the interest rate swaps have been obtained from the counterparties to the agreements and were based on Level 2 observable inputs using proprietary models and estimates about relevant future market conditions. The fair values of the foreign exchange contracts were based on Level 2 observable inputs using quoted market prices for similar assets in an active market. The counterparties to the derivative financial instruments are major international financial institutions. The Company is exposed to credit risk for the net exchanges under these agreements, but not for the notional amounts. As of June 30, 2024, the Company did not anticipate non-performance by any of its counterparties. The amounts of gains and losses, realized and unrealized, related to the Company’s derivative financial instruments designated as hedging instruments are recognized in other comprehensive income, net of taxes, as follows (in thousands): Three Months Ended Six Months Ended Derivatives designated as hedging instruments 2024 2023 2024 2023 Interest rate swaps $ — $ — $ — $ (120) Foreign exchange contracts 22 (300) 223 (1,333) $ 22 $ (300) $ 223 $ (1,453) Realized gains and losses on the interest rate swaps that are reported in other comprehensive income are reclassified into earnings as the interest expense on the debt is recognized. The Company’s interest rate swaps that were designated as hedging instruments had an aggregate notional value of $25.0 million and matured during the three months ended March 31, 2023. Realized gains and losses on foreign exchange contracts that are reported in other comprehensive income are reclassified into cost of sales as the underlying inventory purchased is sold. During the three and six months ended June 30, 2024, the Company reclassified $0.02 million and $0.2 million, respectively, of cash flow hedges in accumulated other comprehensive losses to earnings, related to foreign exchange contracts recognized in cost of sales. At June 30, 2024, the estimated amount of existing net losses expected to be reclassified into earnings within the next 12 months was below $0.1 million. During the three months ended June 30, 2023, the Company reclassified $0.04 million of cash flow hedges in accumulated other comprehensive losses to earnings. This was a gain of $0.04 million related to foreign exchange contracts recognized in cost of sales. During the six months ended June 30, 2023, the Company reclassified $0.9 million of cash flow hedges in accumulated other comprehensive losses to earnings. This was comprised of a gain of $0.1 million related to realized interest rate swap and a gain of $0.8 million related to foreign exchange contracts recognized in cost of sales. Interest and mark to market (losses) gains related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands): Three Months Ended Six Months Ended Derivatives not designated as hedging instruments Location of gain (loss) 2024 2023 2024 2023 Interest rate swaps Mark to market (loss) gain on interest rate derivatives $ (82) $ 197 $ (256) $ (37) Interest expense 309 196 530 361 $ 227 $ 393 $ 274 $ 324 |
STOCK COMPENSATION
STOCK COMPENSATION | 6 Months Ended |
Jun. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
STOCK COMPENSATION | STOCK COMPENSATION On June 20, 2024, the stockholders of the Company approved an amendment and restatement of the Company's Amended and Restated 2000 Long Term Incentive Plan (the "Plan"). The amendment and restatement of the Plan revised the terms and conditions of the Plan to, among other things, increase the shares available for grant under the Plan by 1,500,000 shares. As of June 30, 2024, there were 1,804,161 shares available for the grant of awards under the Plan, assuming maximum performance of performance-based awards. Option Awards A summary of the Company’s stock option activity and related information for the six months ended June 30, 2024 is as follows: Options Weighted- Weighted- Aggregate Options outstanding, January 1, 2024 999,500 $ 13.31 Grants 50,000 9.76 Expirations (252,000) 18.68 Options outstanding, June 30, 2024 797,500 11.40 5.2 $ 197 Options exercisable, June 30, 2024 674,500 $ 11.78 4.5 $ 97 Total unrecognized stock option expense remaining (in thousands) $ 495 Weighted-average years expected to be recognized over 1.8 The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value that would have been received by the option holders had all option holders exercised their stock options on June 30, 2024. The intrinsic value is calculated for each in-the-money stock option as the difference between the closing price of the Company’s common stock on June 30, 2024 and the exercise price. Restricted Stock A summary of the Company’s restricted stock activity and related information for the six months ended June 30, 2024 is as follows: Restricted Weighted- Non-vested restricted shares, January 1, 2024 597,528 $ 8.44 Grants 313,199 9.54 Vested (306,425) 7.53 Cancellations (8,599) 10.07 Non-vested restricted shares, June 30, 2024 595,703 $ 9.46 Total unrecognized compensation expense remaining (in thousands) $ 4,976 Weighted-average years expected to be recognized over 1.7 The total fair value of restricted stock that vested during the six months ended June 30, 2024 was $2.8 million. Performance shares Each performance award represents the right to receive up to 150% of the target number of shares of common stock. The number of shares of common stock earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board. The shares are subject to the terms and conditions of the Company’s Plan. A summary of the Company’s performance-based award activity and related information for the six months ended June 30, 2024 is as follows: Performance- based stock awards (1) Weighted- Non-vested performance-based awards, January 1, 2024 486,972 $ 10.44 Grants 219,975 9.76 Vested (152,188) 14.18 Cancellations (23,815) 13.35 Non-vested performance-based awards, June 30, 2024 530,944 $ 8.96 Total unrecognized compensation expense remaining (in thousands) (2) $ 2,437 Weighted-average years expected to be recognized over 2.3 (1) Represents the target number of shares to be issued for each performance-based award. (2) The performance metric for the performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards. The total fair value of performance-based awards that vested during the six months ended June 30, 2024 was $1.5 million. Cash-settled performance-based awards Each cash-settled performance-based award represents the right to receive up to 150% of the target number of deferred stock units with payment in cash equivalent to the value of one share of the Company's common stock. The number of deferred stock units earned will be determined based on the attainment of specified performance goals at the end of the performance period, as determined by the Compensation Committee of the Board. The cash-settled performance-based awards are subject to the terms and conditions of the Company’s Plan. A summary of the Company’s cash-settled performance-based awards activity and related information for the six months ended June 30, 2024 is as follows: Cash-settled performance-based awards (1) Weighted- Non-vested cash-settled performance-based awards, January 1, 2024 83,611 $ 6.71 Cancellations (1,269) 8.44 Non-vested cash-settled performance-based awards, June 30, 2024 82,342 $ 8.59 Total unrecognized compensation expense remaining (in thousands) (2) $ — Weighted-average years expected to be recognized over 0.0 (1) Represents the target number of units to be settled in cash. (2) The performance metric for the cash-settled performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards. The Company recorded stock compensation expense as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, Stock Compensation Expense Components 2024 2023 2024 2023 Equity based stock option expense $ 60 $ 50 $ 110 $ 179 Restricted and performance-based stock awards expense 984 960 1,733 1,697 Stock compensation expense for equity based awards $ 1,044 $ 1,010 $ 1,843 $ 1,876 Liability based stock option expense (7) 1 1 (4) Total Stock Compensation Expense $ 1,037 $ 1,011 $ 1,844 $ 1,872 |
INCOME (LOSS) PER COMMON SHARE
INCOME (LOSS) PER COMMON SHARE | 6 Months Ended |
Jun. 30, 2024 | |
Earnings Per Share [Abstract] | |
INCOME (LOSS) PER COMMON SHARE | LOSS PER COMMON SHARE Basic loss per common share has been computed by dividing net loss by the weighted-average number of shares of the Company’s common stock outstanding during the relevant period. Diluted loss per common share adjusts net loss and basic loss per common share for the effect of all potentially dilutive shares of the Company’s common stock. Anti-dilutive securities are not included in the computation of diluted earnings per share under the treasury stock method. The calculations of basic and diluted loss per common share for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended Six Months Ended 2024 2023 2024 2023 (in thousands, except per share amounts) Net loss – Basic and Diluted $ (18,167) $ (6,520) $ (24,427) $ (15,325) Weighted-average shares outstanding – Basic 21,421 21,123 21,399 21,174 Effect of dilutive securities: Stock options and other stock awards — — — — Weighted-average shares outstanding – Diluted 21,421 21,123 21,399 21,174 Basic loss per common share $ (0.85) $ (0.31) $ (1.14) $ (0.72) Diluted loss per common share $ (0.85) $ (0.31) $ (1.14) $ (0.72) Antidilutive Securities (1) 1,507 1,624 1,556 1,603 (1) Stock options and other stock awards that have been excluded from the denominator as their inclusion would have been anti-dilutive. |
INCOME TAXES
INCOME TAXES | 6 Months Ended |
Jun. 30, 2024 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | INCOME TAXES Income tax benefit of $0.1 million and income tax provision of $0.2 million for the three and six months ended June 30, 2024, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax benefit rate of 0.3% and provision rate of (0.7)%, respectively. The effective tax rate for the three months ended June 30, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to the expiration of non-qualified stock options and the vesting of equity-based awards, where the book expense exceeded the tax deduction upon vesting, and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. The negative rate for the six months ended June 30, 2024 reflects tax expense on a pretax financial reporting loss. The effective tax rate for the six months ended June 30, 2024 differs from the federal statutory income tax rate of 21.0% primarily due to foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. Income tax provision of $1.2 million and income tax benefit of $0.1 million for the three and six months ended June 30, 2023, respectively, represent taxes on both U.S. and foreign earnings at a combined effective income tax provision rate of 212.3% and income tax benefit rate of 1.6%, respectively. The effective tax rate for the three months ended June 30, 2023 differs from the federal statutory income tax rate of 21.0% primarily due to state and local tax expense, the impact of non-deductible expenses, and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance, partially offset by a benefit for federal credits. The effective tax rate for the six months ended June 30, 2023 differs from the federal statutory income tax rate of 21.0% primarily due to state and local tax expense and foreign losses for which no tax benefit is recognized as such amounts are fully offset with a valuation allowance. The Company has identified the following jurisdictions as “major” tax jurisdictions: U.S. Federal, California, Massachusetts, New Jersey, New York and the United Kingdom. The Company evaluates its tax positions on a quarterly basis and revises its estimates accordingly. There were no material changes to the Company’s uncertain tax positions, interest, or penalties during the three-month periods ended June 30, 2024 and June 30, 2023. |
BUSINESS SEGMENTS
BUSINESS SEGMENTS | 6 Months Ended |
Jun. 30, 2024 | |
Segment Reporting [Abstract] | |
BUSINESS SEGMENTS | BUSINESS SEGMENTS The Company has two reportable segments, U.S. and International. The Company has segmented its operations to reflect the manner in which management reviews and evaluates the results of its operations. The U.S. segment includes the Company’s primary domestic business that designs, markets and distributes its products to retailers, distributors and directly to consumers through its own websites. The International segment consists of certain business operations conducted outside the U.S.. Management evaluates the performance of the U.S. and International segments based on net sales and income from operations. Such measures give recognition to specifically identifiable operating costs such as cost of sales, distribution expenses and selling, general and administrative expenses. Certain general and administrative expenses, such as senior executive salaries and benefits, stock compensation, director fees, and accounting, legal fees and consulting fees, are not allocated to the specific segments and are reflected as unallocated corporate expenses. Three Months Ended Six Months Ended 2024 2023 2024 2023 (in thousands) Net sales U.S. $ 130,503 $ 134,979 $ 260,983 $ 268,464 International 11,163 11,457 22,925 23,407 Total net sales $ 141,666 $ 146,436 $ 283,908 $ 291,871 Income from operations U.S. $ 9,189 $ 11,736 $ 18,631 $ 17,690 International (2,932) (2,829) (6,021) (4,721) Unallocated corporate expenses (5,090) (4,511) (9,613) (10,379) Income from operations $ 1,167 $ 4,396 $ 2,997 $ 2,590 Depreciation and amortization U.S. $ 4,612 $ 4,646 $ 9,268 $ 9,264 International 282 279 565 531 Total depreciation and amortization $ 4,894 $ 4,925 $ 9,833 $ 9,795 June 30, December 31, (in thousands) Assets U.S. $ 529,983 $ 560,716 International 80,039 90,237 Unallocated corporate 6,942 16,189 Total Assets $ 616,964 $ 667,142 |
CONTINGENCIES
CONTINGENCIES | 6 Months Ended |
Jun. 30, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
CONTINGENCIES | CONTINGENCIES Wallace EPA Matter Wallace Silversmiths de Puerto Rico, Ltd. (“WSPR”), a wholly-owned subsidiary of the Company, operates a manufacturing facility in San Germán, Puerto Rico that is leased from the Puerto Rico Industrial Development Company (“PRIDCO”). In March 2008, the U.S. Environmental Protection Agency (the “EPA”) announced that the San Germán Ground Water Contamination site in Puerto Rico (the “Site”) had been added to the Superfund National Priorities List due to contamination present in the local drinking water supply. In May 2008, WSPR received from the EPA a Notice of Potential Liability and Request for Information pursuant to 42 U.S.C. Sections 9607(a) and 9604(e) of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). In July 2011, WSPR received a letter from the EPA requesting access to the property that it leases from PRIDCO to conduct an environmental investigation, and the Company granted such access. In February 2013, the EPA requested access to conduct a further environmental investigation at the property. PRIDCO agreed to such access and the Company consented. The EPA conducted a further investigation during 2013 and, in April 2015, notified the Company and PRIDCO that the results from vapor intrusion sampling may warrant the implementation of measures to mitigate potential exposure to sub-slab soil gas. The Company reviewed the information provided by the EPA and requested that PRIDCO, as the property owner, find and implement a solution acceptable to the EPA. While WSPR did not cause the sub-surface condition that resulted in the potential for vapor intrusion, in order to protect the health of its employees and continue its business operations, it has nevertheless implemented corrective action measures to prevent vapor intrusion, such as sealing the floors of the building and conducting periodic air monitoring to address potential exposure. On August 13, 2015, the EPA released its remedial investigation and feasibility study (“RI/FS”) for the Site. On December 11, 2015, the EPA issued the Record of Decision (“ROD”) for an initial operable unit (“OU-1”), electing to implement its preferred remedy which consists of soil vapor extraction and dual-phase extraction/in-situ treatment. This selected remedy includes soil vapor extraction (“SVE”) to address soil (vadose zone) source areas at the Site, impermeable cover as necessary for the implementation of SVE, dual phase extraction in the shallow saprolite zone, and in-situ treatment as needed to address residual sources. The EPA’s total net present worth estimated cost for its selected remedy is $7.3 million. In February 2017, the EPA indicated that it planned to expand its field investigation for the RI/FS to a second operable unit (“OU-2”) to determine the nature and extent of the groundwater contamination at and from the Site and to determine the nature of the remedial action needed to address the contamination. The EPA requested access to the property occupied by WSPR to install monitoring wells and to undertake groundwater sampling as part of this expanded investigation. WSPR consented to the EPA’s access request, provided that the EPA received PRIDCO’s consent as the property owner. WSPR never used the primary contaminant of concern and did not take up its tenancy at the Site until after the EPA had discovered the contamination in the local water supply. The EPA has also issued notices of potential liability to a number of other entities affiliated with the Site, which used the contaminants of concern. In December 2018, the Company, WSPR, and other identified potentially responsible parties affiliated with the Site entered into tolling agreements with the U.S. government to extend the statute of limitations for potential claims for the recovery of response costs for the initial operable unit under Section 107 of CERCLA. The tolling agreements have been extended multiple times and currently expire in November 2025. The tolling agreements do not constitute in any way an admission or acknowledgment of any fact, conclusion of law, or liability by the parties to the agreements. The EPA released its proposed plan for OU-2 in July 2019, and on September 30, 2019, the EPA issued the ROD for OU-2. The EPA elected to implement its preferred remedy consisting of in-situ treatment of groundwater and a monitored natural attenuation program including monitoring of the plume fringe at the Site. The EPA’s estimated total net present worth cost for its selected remedy for OU-2 is $17.3 million, and the EPA is currently leading remediation of OU-2. In August 2021, WSPR received a Notice of Liability for the Site from the Department of Justice on behalf of the EPA, and in September 2021, WSPR responded with a good faith offer to conduct additional testing and remedial design work for OU-1. WSPR has actively participated in negotiations among the U.S. Government (the Department of Justice and the EPA) and other potentially responsible parties with respect to the remedial work at OU-1, which negotiations culminated in the finalization of a Consent Decree for Remedial Design and Remedial Action at Operable Unit One of the San German Groundwater Contamination Site (“Consent Decree”). On July 26, 2023, the U.S. Government filed a complaint in United States District Court for the District of Puerto Rico for the purpose of seeking judicial approval of the Consent Decree. As required by applicable regulations, the U.S. Government simultaneously lodged the Consent Decree for public comment. No comments were received during the public comment period. On September 6, 2023, at the conclusion of the public comment period, the U.S. Government filed a Motion to Enter the Consent Decree, which the court granted on December 1, 2023, thereby effectuating the Consent Decree. On January 10, 2024, EPA issued a notice to proceed with the OU-1 remedial work. The Company thereafter commenced remedial work on OU-1 in accordance with the Consent Decree. The Company has reserved $5.6 million to cover probable and estimable liabilities with respect to the above remedial design and remedial action for the initial operable unit. However, it is not possible at this time for the Company to estimate its share of its ultimate liability for the Site. In the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material. U.S. Customs and Border Protection matter By letter dated August 26, 2019, the Company was advised that U.S. Customs and Border Protection ("CBP") had commenced an investigation, pursuant to 19 U.S.C. §1592, regarding the Company’s tariff classification of certain tableware and kitchenware. The issue centers on whether such merchandise meets the criteria for reduced duty rates as specified sets as those terms are defined in Chapter 69, Note 6(b), Harmonized Tariff System of the United States. The period of investigation is stated to be from August 26, 2014 to the present. Since being notified of the investigation, the Company has obtained a significant amount of evidence that, the Company believes, supports that the imported products were properly classified as specified sets. The Company's counsel filed a Lead Protest and Application for Further Review with CBP on February 5, 2020 (the "Lead Protest") relating to a single shipment made during the investigation period. CBP approved the Company’s Lead Protest on June 8, 2020 stating that the specified set requirement was fulfilled with respect to the protested shipment based on information provided by the Company. Based on this decision, no additional duties will be owed for the seven tableware collections imported in this shipment. The Company also compiled and submitted to CBP a complete set of supporting documents for three additional protests (for the remaining 29 tableware collections that were imported by the Company under the protested shipments). One of the additional protests was approved on October 15, 2020; the other two remain pending. If the CBP approves these additional claims and accepts the evidence presented, then no additional duties will be owed for the remaining protested shipments. Because the period of investigation covers a five-year period, the Company is compiling supporting documentation packages for all tableware collections imported during this period. In the event CBP accepts the evidence presented, then no additional duties or penalties will be owed. If CBP rejects the Company’s position, then the estimated amount of duties that could be owed is $0.1 million. In such event, it is reasonably possible that additional penalties could be assessed, depending upon the level of culpability found, of up to $0.3 million for negligence and up to $0.6 million for gross negligence. In the event penalties are assessed, the Company will have the opportunity to further contest CBP’s findings and seek cancellation or mitigation of such assessments. Accordingly, based on the above uncertainties and variables, the Company considers the potential losses related to this matter to be reasonably possible, but not probable. However, in the event of one or more adverse determinations related to this matter, it is possible that the ultimate liability resulting from this matter and the impact on the Company’s results of operations could be material. Other The Company is, from time to time, involved in other legal proceedings. The Company believes that other current litigation is routine in nature and incidental to the conduct of the Company’s business and that none of this litigation, individually or collectively, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. |
OTHER
OTHER | 6 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
OTHER | OTHER Cash dividends Dividends declared in the six months ended June 30, 2024 were as follows: Dividend per share Date declared Date of record Payment date $0.0425 3/8/2024 5/1/2024 5/15/2024 $0.0425 6/20/2024 8/1/2024 8/15/2024 During the six months ended June 30, 2024, the Company paid dividends of $2.0 million. This included payments made on February 15, 2024 and May 15, 2024 of $0.9 million and $0.9 million to stockholders of record on February 1, 2024 and May 1, 2024, and payments of $0.2 million for dividends payable upon the vesting of restricted shares and performance shares. In the three months ended June 30, 2024, the Company reduced retained earnings for the accrual of $1.0 million relating to the dividend payable on August 15, 2024. On August 6, 2024, the Board declared a quarterly dividend of 0.0425 per share of common stock payable on November 15, 2024 to stockholders of record on November 1, 2024. Stock repurchase program On March 14, 2022, the Company announced that its Board authorized the repurchase of up to $20.0 million of the Company’s common stock, replacing the Company’s previously-authorized $10.0 million share repurchase program. The repurchase authorization permits the Company to effect the repurchases from time to time through open market purchases and privately negotiated transactions. No repurchases were effected during the six months ended June 30, 2024. As of June 30, 2024, the remaining dollar amount available for repurchases under the Board authorized plan was $11.1 million. Supplemental cash flow information Six Months Ended 2024 2023 (in thousands) Supplemental disclosure of cash flow information: Cash paid for interest $ 9,853 $ 10,453 Cash paid for taxes, net of refunds 4,193 3,188 Components of accumulated other comprehensive loss, net Three Months Ended Six Months Ended 2024 2023 2024 2023 (in thousands) Accumulated translation adjustment: Balance at beginning of period $ (32,574) $ (34,511) $ (32,614) $ (36,072) Translation adjustment during period 53 1,237 93 2,798 Amounts reclassified from accumulated other comprehensive loss (1) 14,152 — 14,152 — Net change in translation adjustment 14,205 1,237 14,245 2,798 Balance at end of period $ (18,369) $ (33,274) $ (18,369) $ (33,274) Accumulated deferred gains (losses) on cash flow hedges: Balance at beginning of period $ 67 $ (230) $ (134) $ 923 Change in unrealized gains (losses) 2 (261) 72 (511) Amounts reclassified from accumulated other comprehensive loss: Settlement of cash flow hedge (2) 20 (39) 151 (942) Net change in cash flow hedges, net of taxes of $0, $0, $0, $(2) 22 (300) 223 (1,453) Balance at end of period $ 89 $ (530) $ 89 $ (530) Accumulated effect of retirement benefit obligations: Balance at beginning of period $ (738) $ (693) $ (751) $ (705) Amounts reclassified from accumulated other comprehensive loss: (3) Amortization of actuarial loss, net of taxes of $(4), $(4), $(8), $(8) 12 11 25 23 Balance at end of period $ (726) $ (682) $ (726) $ (682) Total accumulated other comprehensive loss at end of period $ (19,006) $ (34,486) $ (19,006) $ (34,486) (1) Amounts reclassified to the Vasconia investment carrying value as a result of the discontinuation of the equity method investment of accounting and subsequently recognized as a loss on equity securities in the unaudited condensed consolidated statements of operations, to reduce the Vasconia investment to its fair value. Refer to NOTE 4 —INVESTMENT for additional information. (2) Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations. (3) Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Pay vs Performance Disclosure | ||||||
Net loss | $ (18,167) | $ (6,260) | $ (6,520) | $ (8,805) | $ (24,427) | $ (15,325) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Jun. 30, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
BASIS OF PRESENTATION AND SUM_2
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Policies) | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Basis of presentation | Basis of presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, which consist of normal recurring accruals and non-recurring adjustments, considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Operating results for the three and six months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the year ending December 31, 2024. The Company’s business and working capital needs are seasonal, with a majority of sales occurring in the third and fourth quarters. In 2023 and 2022, net sales for the third and fourth quarters accounted for 57% and 54% of total annual net sales, respectively. In anticipation of the pre-holiday shipping season, inventory levels increase primarily in the June through October time period. The Company’s current estimates contemplate current and expected future conditions, as applicable, however it is reasonably possible that actual conditions could differ from expectations, which could materially affect the Company’s results of operations and financial position. |
Revenue recognition and Cost of sales | Revenue recognition The Company sells products wholesale, to retailers and distributors, and retail, directly to the consumer. Wholesale sales and retail sales are primarily recognized at the point in time the customer obtains control of the products, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those products. The Company offers various sales incentives and promotional programs to its customers in the normal course of business. These incentives and promotions typically include arrangements such as cooperative advertising, buydowns, volume rebates and discounts. These arrangements and an estimate for products expected to be returned are reflected as reductions of revenue at the time of sale. See NOTE 2 —REVENUE to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information. Cost of sales Cost of sales consist primarily of costs associated with the production and procurement of product, inbound freight costs, purchasing costs, royalties, and other product procurement related charges. |
Distribution expenses | Distribution expenses Distribution expenses consist primarily of warehousing expenses and freight-out expenses. Handling costs of products sold are included in cost of sales. |
Accounts receivable | Accounts receivable The Company periodically reviews the collectability of its accounts receivable and establishes allowances for estimated credit losses that could result from the inability of its customers to make required payments, taking into consideration customer credit history and financial condition, industry and market segment information, credit reports, and expectations of current and future economic conditions. A considerable amount of judgment is required to assess the ultimate realization of these receivables, including assessing the initial and on-going creditworthiness of the Company’s customers. The Company also maintains an allowance for anticipated customer deductions. The allowances for deductions are primarily based on contracts with customers. However, in certain cases, the Company does not have a formal contract and, therefore, customer deductions are non-contractual. To evaluate the reasonableness of non-contractual customer deductions, the Company analyzes currently available information and historical trends of deductions. |
Receivable purchase agreement | Receivable purchase agreement The Company has an uncommitted Receivables Purchase Agreement with HSBC Bank USA, National Association (“HSBC”) as Purchaser (the “Receivables Purchase Agreement”). The sale of accounts receivable, under the Receivables Purchase Agreement with HSBC, is excluded from the Company’s unaudited condensed consolidated balance sheets at the time of sale and the related sale expense is included in selling, general and administrative expenses in the Company’s unaudited condensed consolidated statements of operations. The Company did not sell receivables to HSBC during the three and six months ended June 30, 2024 and June 30, 2023. |
Inventory | Inventory Inventory consists principally of finished goods sourced from third-party suppliers. Inventory also includes finished goods, work in process and raw materials related to the Company’s manufacture of sterling silver products. Inventory is priced using the lower of cost (first-in, first-out basis) or net realizable value. The Company estimates the selling price of its inventory on a product-by-product basis based on the current selling environment. If the estimated selling price is lower than the inventory’s cost, the Company reduces the value of the inventory to its net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable cost of completion, disposal and transportation. |
Fair value of financial instruments | Fair value of financial instruments The Company determined that the carrying amounts of cash and cash equivalents, accounts receivable and accounts payable are reasonable estimates of their fair values because of their short-term nature. The Company determined that the carrying amounts of borrowings outstanding under its ABL Agreement and Term Loan (each as defined in NOTE 6 — DEBT to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q) approximate fair value since such borrowings bear interest at variable market rates. |
Derivatives | Derivatives The Company accounts for derivative instruments in accordance with Accounting Standard Codification (“ASC”) Topic 815, Derivatives and Hedging ( “ASC 815” ) . ASC 815 requires that all derivative instruments be recognized on the balance sheet at fair value as either an asset or liability. Changes in the fair value of derivatives that qualify as hedges and have been designated as part of a hedging relationship for accounting purposes have no net impact on earnings until the hedged item is recognized in earnings. The changes in the fair value of hedges are included in accumulated other comprehensive loss and are subsequently recognized in the Company’s unaudited condensed consolidated statements of operations to mirror the location of the hedged items impacting earnings. Changes in fair value of derivatives that do not qualify as hedging instruments for accounting purposes are recorded in the Company’s unaudited condensed consolidated statements of operations. |
Goodwill, intangible assets and long-lived assets | Goodwill, intangible assets and long-lived assets Goodwill and intangible assets deemed to have indefinite lives are not amortized but, instead, are subject to an annual impairment assessment. Additionally, if events or conditions were to indicate the carrying value of a reporting unit may not be recoverable, the Company would evaluate goodwill and other intangible assets for impairment at that time. As it relates to the goodwill assessment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the quantitative goodwill impairment testing described in the Financial Accounting Standards Board's (“FASB”) Accounting Standards Update No. (“ASU”) Topic 350, Intangibles – Goodwill and Other. If, after assessing qualitative factors, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the quantitative test is unnecessary and the Company’s goodwill is considered to be unimpaired. However, if based on the Company’s qualitative assessment it concludes that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, or if the Company elects to bypass the qualitative assessment, the Company will proceed with performing the quantitative impairment test. The Company reviews goodwill and other intangibles that have indefinite lives for impairment annually as of October 1 or when events or changes in circumstances indicate the carrying value of these assets might exceed their current fair values. Impairment testing is based upon the best information available, including estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. The Company performed its annual impairment assessment of its U.S. reporting unit as of October 1, 2023 by comparing the fair value of the reporting unit with its carrying value. The Company performed the analysis using a discounted cash flow and market multiple method. As of October 1, 2023, the fair value of the U.S. reporting unit exceeded the carrying value of goodwill by 4%. The significant assumptions used under the income approach, or discounted cash flow method, are projected net sales, projected earnings before interest, tax, depreciation and amortization (“EBITDA”) and the cost of capital. Projected net sales and projected EBITDA were determined to be significant assumptions because they are the primary drivers of the projected cash flows in the discounted cash flow fair value model. Cost of capital was also determined to be a significant assumption as it is the discount rate used to calculate the current fair value of those projected cash flows. Although the Company believes the assumptions and estimates made are reasonable and appropriate, different assumptions and estimates could materially impact its reported financial results. In addition, sustained declines in the Company’s stock price and related market capitalization could impact key assumptions in the overall estimated fair values of its reporting units and could result in non-cash impairment charges that could be material to the Company’s consolidated balance sheet or results of operations. Should the carrying value of a reporting unit be in excess of the estimated fair value of that reporting unit, an impairment charge will be recorded to reduce the reporting unit to fair value. The Company also evaluates qualitative factors to determine whether impairment indicators exist for its indefinite-lived intangibles and performs quantitative tests if required. These tests can include the relief from royalty model or other valuation models. The significant assumptions used in the relief from royalty model are future net sales for the related brands, royalty rates and the cost of capital to determine the fair value of the indefinite-lived intangibles. The Company completed the quantitative impairment analysis for its indefinite-lived asset as of October 1, 2023, by comparing the fair value of the indefinite-lived trade name to the carrying value using a relief from royalty method. As of October 1, 2023, the fair value of the Company’s indefinite-lived trade name exceeded its carrying value by 7%. While the indefinite-lived trade name was not determined to be impaired, if the indefinite-lived trade name does not perform as projected or if market factors utilized in the impairment analysis deteriorate, including an unfavorable change in the weighted average cost of capital, could materially affect the expected cash flows, and such impacts could potentially result in a material non-cash impairment charge. Long-lived assets, including intangible assets deemed to have finite lives, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Impairment indicators include, among other conditions, cash flow deficits, historic or anticipated declines in revenue or operating profit or material adverse changes in the business climate that indicate that the carrying amount of an asset may be impaired. When impairment indicators are present, the recoverability of the asset is measured by comparing the carrying value of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset is not recoverable, the impairment to be recognized is measured by the amount by which the carrying amount of each long-lived asset exceeds the fair value of the asset. See NOTE 5 — INTANGIBLE ASSETS to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information. |
Leases | Leases The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in operating lease right-of-use assets on the condensed consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the current portion of operating lease liability and operating lease liabilities, respectively, on the condensed consolidated balance sheets. Finance leases are included in property and equipment, net, accrued expenses and other long-term liabilities. The Company’s finance leases are not material to the Company’s condensed consolidated balance sheets. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. The operating lease ROU asset may also include any lease payments made, adjusted for any prepaid or accrued rent payments, lease incentives, and initial direct costs incurred. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. For certain equipment leases, the Company applies a portfolio approach to effectively account for any ROU assets and lease liabilities. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. |
Employee healthcare | Employee healthcare The Company self-insures certain portions of its health insurance plan. The Company maintains an accrual for estimated unpaid claims and claims incurred but not yet reported (“IBNR”). Although management believes that it uses the best information available to estimate IBNR claims, actual claims may vary significantly from estimated claims. |
Restructuring Expenses | Restructuring expenses Costs associated with restructuring activities are recorded at fair value when a liability has been incurred. Generally, a liability has been incurred at the communication date for severance. Charges associated with lease terminations, related to restructuring activities, are recognized at the effective date of the lease modification. During the six months ended June 30, 2023, the Company incurred $0.8 million of unallocated corporate expense related to the termination payment with its former Executive Chairman, Jeffrey Siegel (the “Executive Chairman”). On November 1, 2022, the Company entered into a transition agreement with its Executive Chairman which terminated his employment with the Company, effective March 31, 2023. The employment agreement provided for a one-time payment, which was paid on April 7, 2023. |
New accounting pronouncements | New accounting pronouncements Updates not listed below were assessed and either determined to not be applicable or are expected to have a minimal effect on the Company’s financial position, results of operations, and disclosures. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures: which enhances the disclosures required for operating segments in the Company’s annual and interim consolidated financial statements. The new guidance is effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024 on a retrospective basis. Early adoption is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures: This guidance is intended to enhance the transparency and decision usefulness of income tax disclosures. The amendments in ASU 2023-09 address investor requests for enhanced income tax information primarily through changes to the rate reconciliation and income taxes paid information. Early adoption is permitted. The new guidance is effective for public business entities for annual periods beginning after December 15, 2024 on a prospective basis. Retrospective application is permitted. Management is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures. |
BASIS OF PRESENTATION AND SUM_3
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Accounting Policies [Abstract] | |
Components of Inventory | The components of inventory were as follows (in thousands): June 30, December 31, 2023 Finished goods $ 198,776 $ 180,860 Work in process 28 106 Raw materials 9,676 7,681 Total $ 208,480 $ 188,647 |
REVENUE (Tables)
REVENUE (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following tables present the Company’s net sales disaggregated by segment, product category and geographic region for the three and six months ended June 30, 2024 and 2023 (in thousands): Three Months Ended Six Months Ended June 30, June 30, 2024 2023 2024 2023 U.S. segment Kitchenware $ 80,787 $ 84,015 $ 164,317 $ 169,747 Tableware 26,341 26,149 52,100 50,148 Home Solutions 23,375 24,815 44,566 48,569 Total U.S. segment 130,503 134,979 260,983 268,464 International segment 11,163 11,457 22,925 23,407 Total net sales $ 141,666 $ 146,436 $ 283,908 $ 291,871 United States $ 118,954 $ 127,295 $ 239,457 $ 254,541 United Kingdom 7,150 7,679 14,616 16,291 Rest of World 15,562 11,462 29,835 21,039 Total net sales $ 141,666 $ 146,436 $ 283,908 $ 291,871 |
LEASES (Tables)
LEASES (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Leases [Abstract] | |
Lease, Cost | The components of lease expense for the three and six months ended June 30, 2024 and 2023 were as follows (in thousands): Three Months Ended June 30, Six Months Ended 2024 2023 2024 2023 Operating lease expenses (1) : Fixed lease expense $ 4,265 $ 4,232 $ 8,528 $ 8,406 Variable lease expense 1,650 1,324 3,018 2,750 Total $ 5,915 $ 5,556 $ 11,546 $ 11,156 (1) Expenses are recorded within distribution expenses and selling, general and administrative expenses on the unaudited condensed consolidated statement of operations. |
Schedule Of Supplemental Cash Flow Information Related To Leases | Supplemental cash flow information for lease related liabilities and assets for the six months ended June 30, 2024 and 2023 were as follows (in thousands): Six Months Ended 2024 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 9,493 $ 9,661 Six Months Ended 2024 2023 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 423 $ 2,715 |
Lessee, Operating Lease, Liability, Maturity | The aggregate future lease payments for operating leases as of June 30, 2024 were as follows (in thousands): Operating 2024 (excluding the six months ended June 30, 2024) $ 9,536 2025 18,888 2026 18,511 2027 14,290 2028 12,830 2029 6,682 Thereafter 11,762 Total lease payments 92,499 Less: Interest (15,046) Present value of lease payments $ 77,453 |
Schedule Of Average Lease Terms And Discount Rates | Average lease terms and discount rates were as follows: June 30, 2024 Operating leases: Weighted-average remaining lease term (years) 5.6 Weighted-average discount rate 6.4 % |
INVESTMENTS (Tables)
INVESTMENTS (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Summarized Equity in Earnings, Net of Taxes [Table] | Three Months Ended Six Months Ended 2024 2023 2024 2023 Vasconia equity in losses, net of taxes $ — $ (1,422) $ (2,092) $ (2,146) Impairment on investment in Vasconia — (4,441) — (6,494) Equity in losses, net of taxes $ — $ (5,863) $ (2,092) $ (8,640) |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Intangible Assets and Goodwill [Table Text Block] | Intangible assets consisted of the following as of June 30, 2024 and December 31, 2023 (in thousands): June 30, 2024 December 31, 2023 Gross Accumulated Net Gross Accumulated Net Goodwill (1) $ 33,237 $ — $ 33,237 $ 33,237 $ — $ 33,237 Indefinite-lived intangible assets: Trade names (1) 42,000 — 42,000 42,000 — 42,000 Finite-lived intangible assets: Licenses 15,847 (12,337) 3,510 15,847 (12,110) 3,737 Trade names (2) 62,478 (25,926) 36,552 62,493 (23,862) 38,631 Customer relationships (2) 143,157 (68,585) 74,572 143,158 (63,630) 79,528 Other (2) 5,871 (4,118) 1,753 5,872 (3,872) 2,000 Total $ 302,590 $ (110,966) $ 191,624 $ 302,607 $ (103,474) $ 199,133 (1) The gross and net value at June 30, 2024 and December 31, 2023 reflect a reduction of $91.7 million in impairment charges on goodwill and $1.0 million in impairment charges on indefinite-lived intangible assets. (2) The gross value and accumulated amortization at June 30, 2024 and December 31, 2023 reflect a reduction of $44.1 million and $(29.3) million, respectively, for the net $14.8 million previous impairment charge on finite-lived intangible assets within the international segment and a $6.5 million reduction in gross value for previous impairment charges on finite-lived intangible assets within the U.S. segment. |
DEBT (Tables)
DEBT (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Line of Credit Facilities | As of June 30, 2024 and December 31, 2023, the total availability under the ABL Agreement were as follows (in thousands): June 30, 2024 December 31, 2023 Maximum aggregate principal allowed $ 176,700 $ 181,919 Outstanding borrowings under the ABL Agreement (32,635) (60,395) Standby letters of credit (8,534) (2,894) Total availability under the ABL Agreement $ 135,531 $ 118,630 |
Schedule of Long-term Debt Instruments | The current and non-current portions of the Company’s Term Loan included in the condensed consolidated balance sheets were as follows (in thousands): June 30, 2024 December 31, 2023 Current portion of Term Loan: Term Loan payment $ 7,500 $ 7,500 Estimated Excess Cash Flow principal payment 2,000 — Estimated unamortized debt issuance costs (2,678) (2,758) Total Current portion of Term Loan $ 6,822 $ 4,742 Non-current portion of Term Loan: Term Loan, net of current portion $ 138,625 $ 142,500 Estimated unamortized debt issuance costs (5,347) (6,666) Total Non-current portion of Term Loan $ 133,278 $ 135,834 |
DERIVATIVES (Tables)
DERIVATIVES (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Fair Values of Derivative Financial Instruments Included in Unaudited Condensed Consolidated Balance Sheets | The fair values of the Company’s derivative financial instruments included in the condensed consolidated balance sheets are presented as follows (in thousands): Derivatives designated as hedging instruments Balance Sheet Location June 30, 2024 December 31, 2023 Foreign exchange contracts Prepaid expenses and other current assets $ 44 $ 56 Accrued expenses 53 144 Derivatives not designated as hedging instruments Balance Sheet Location June 30, 2024 December 31, 2023 Interest rate swaps Prepaid expenses and other current assets $ 553 $ — Other assets — 793 Other long-term liabilities 16 — |
Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments | The amounts of gains and losses, realized and unrealized, related to the Company’s derivative financial instruments designated as hedging instruments are recognized in other comprehensive income, net of taxes, as follows (in thousands): Three Months Ended Six Months Ended Derivatives designated as hedging instruments 2024 2023 2024 2023 Interest rate swaps $ — $ — $ — $ (120) Foreign exchange contracts 22 (300) 223 (1,333) $ 22 $ (300) $ 223 $ (1,453) |
Derivatives Not Designated as Hedging Instruments | Interest and mark to market (losses) gains related to the Company’s derivative financial instruments not designated as hedging instruments that were recognized in earnings are as follows (in thousands): Three Months Ended Six Months Ended Derivatives not designated as hedging instruments Location of gain (loss) 2024 2023 2024 2023 Interest rate swaps Mark to market (loss) gain on interest rate derivatives $ (82) $ 197 $ (256) $ (37) Interest expense 309 196 530 361 $ 227 $ 393 $ 274 $ 324 |
STOCK COMPENSATION (Tables)
STOCK COMPENSATION (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Stock Option Activity and Related Information | A summary of the Company’s stock option activity and related information for the six months ended June 30, 2024 is as follows: Options Weighted- Weighted- Aggregate Options outstanding, January 1, 2024 999,500 $ 13.31 Grants 50,000 9.76 Expirations (252,000) 18.68 Options outstanding, June 30, 2024 797,500 11.40 5.2 $ 197 Options exercisable, June 30, 2024 674,500 $ 11.78 4.5 $ 97 Total unrecognized stock option expense remaining (in thousands) $ 495 Weighted-average years expected to be recognized over 1.8 |
Summary of Restricted Stock Activity | A summary of the Company’s restricted stock activity and related information for the six months ended June 30, 2024 is as follows: Restricted Weighted- Non-vested restricted shares, January 1, 2024 597,528 $ 8.44 Grants 313,199 9.54 Vested (306,425) 7.53 Cancellations (8,599) 10.07 Non-vested restricted shares, June 30, 2024 595,703 $ 9.46 Total unrecognized compensation expense remaining (in thousands) $ 4,976 Weighted-average years expected to be recognized over 1.7 |
Summary of Performance-based Award Activity | A summary of the Company’s performance-based award activity and related information for the six months ended June 30, 2024 is as follows: Performance- based stock awards (1) Weighted- Non-vested performance-based awards, January 1, 2024 486,972 $ 10.44 Grants 219,975 9.76 Vested (152,188) 14.18 Cancellations (23,815) 13.35 Non-vested performance-based awards, June 30, 2024 530,944 $ 8.96 Total unrecognized compensation expense remaining (in thousands) (2) $ 2,437 Weighted-average years expected to be recognized over 2.3 (1) Represents the target number of shares to be issued for each performance-based award. (2) The performance metric for the performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards. |
Share-based Payment Arrangement, Cash Settled Performance Shares, Activity [Table Text Block] | A summary of the Company’s cash-settled performance-based awards activity and related information for the six months ended June 30, 2024 is as follows: Cash-settled performance-based awards (1) Weighted- Non-vested cash-settled performance-based awards, January 1, 2024 83,611 $ 6.71 Cancellations (1,269) 8.44 Non-vested cash-settled performance-based awards, June 30, 2024 82,342 $ 8.59 Total unrecognized compensation expense remaining (in thousands) (2) $ — Weighted-average years expected to be recognized over 0.0 (1) Represents the target number of units to be settled in cash. (2) The performance metric for the cash-settled performance-based awards granted in 2022 is not probable of achievement. Therefore, no compensation expense has been recorded on these awards. |
Summary of Stock Compensation Expense | The Company recorded stock compensation expense as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, Stock Compensation Expense Components 2024 2023 2024 2023 Equity based stock option expense $ 60 $ 50 $ 110 $ 179 Restricted and performance-based stock awards expense 984 960 1,733 1,697 Stock compensation expense for equity based awards $ 1,044 $ 1,010 $ 1,843 $ 1,876 Liability based stock option expense (7) 1 1 (4) Total Stock Compensation Expense $ 1,037 $ 1,011 $ 1,844 $ 1,872 |
INCOME (LOSS) PER COMMON SHARE
INCOME (LOSS) PER COMMON SHARE (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Earnings Per Share [Abstract] | |
Calculations of Basic and Diluted Income (Loss) per Common Share | The calculations of basic and diluted loss per common share for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended Six Months Ended 2024 2023 2024 2023 (in thousands, except per share amounts) Net loss – Basic and Diluted $ (18,167) $ (6,520) $ (24,427) $ (15,325) Weighted-average shares outstanding – Basic 21,421 21,123 21,399 21,174 Effect of dilutive securities: Stock options and other stock awards — — — — Weighted-average shares outstanding – Diluted 21,421 21,123 21,399 21,174 Basic loss per common share $ (0.85) $ (0.31) $ (1.14) $ (0.72) Diluted loss per common share $ (0.85) $ (0.31) $ (1.14) $ (0.72) Antidilutive Securities (1) 1,507 1,624 1,556 1,603 (1) Stock options and other stock awards that have been excluded from the denominator as their inclusion would have been anti-dilutive. |
BUSINESS SEGMENTS (Tables)
BUSINESS SEGMENTS (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Segment Reporting [Abstract] | |
Segment Reporting Information | Three Months Ended Six Months Ended 2024 2023 2024 2023 (in thousands) Net sales U.S. $ 130,503 $ 134,979 $ 260,983 $ 268,464 International 11,163 11,457 22,925 23,407 Total net sales $ 141,666 $ 146,436 $ 283,908 $ 291,871 Income from operations U.S. $ 9,189 $ 11,736 $ 18,631 $ 17,690 International (2,932) (2,829) (6,021) (4,721) Unallocated corporate expenses (5,090) (4,511) (9,613) (10,379) Income from operations $ 1,167 $ 4,396 $ 2,997 $ 2,590 Depreciation and amortization U.S. $ 4,612 $ 4,646 $ 9,268 $ 9,264 International 282 279 565 531 Total depreciation and amortization $ 4,894 $ 4,925 $ 9,833 $ 9,795 June 30, December 31, (in thousands) Assets U.S. $ 529,983 $ 560,716 International 80,039 90,237 Unallocated corporate 6,942 16,189 Total Assets $ 616,964 $ 667,142 |
OTHER (Tables)
OTHER (Tables) | 6 Months Ended |
Jun. 30, 2024 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Cash Dividends Declared | Dividends declared in the six months ended June 30, 2024 were as follows: Dividend per share Date declared Date of record Payment date $0.0425 3/8/2024 5/1/2024 5/15/2024 $0.0425 6/20/2024 8/1/2024 8/15/2024 |
Supplemental Cash Flow Information | Supplemental cash flow information Six Months Ended 2024 2023 (in thousands) Supplemental disclosure of cash flow information: Cash paid for interest $ 9,853 $ 10,453 Cash paid for taxes, net of refunds 4,193 3,188 |
Components of Accumulated Other Comprehensive Loss, Net | Components of accumulated other comprehensive loss, net Three Months Ended Six Months Ended 2024 2023 2024 2023 (in thousands) Accumulated translation adjustment: Balance at beginning of period $ (32,574) $ (34,511) $ (32,614) $ (36,072) Translation adjustment during period 53 1,237 93 2,798 Amounts reclassified from accumulated other comprehensive loss (1) 14,152 — 14,152 — Net change in translation adjustment 14,205 1,237 14,245 2,798 Balance at end of period $ (18,369) $ (33,274) $ (18,369) $ (33,274) Accumulated deferred gains (losses) on cash flow hedges: Balance at beginning of period $ 67 $ (230) $ (134) $ 923 Change in unrealized gains (losses) 2 (261) 72 (511) Amounts reclassified from accumulated other comprehensive loss: Settlement of cash flow hedge (2) 20 (39) 151 (942) Net change in cash flow hedges, net of taxes of $0, $0, $0, $(2) 22 (300) 223 (1,453) Balance at end of period $ 89 $ (530) $ 89 $ (530) Accumulated effect of retirement benefit obligations: Balance at beginning of period $ (738) $ (693) $ (751) $ (705) Amounts reclassified from accumulated other comprehensive loss: (3) Amortization of actuarial loss, net of taxes of $(4), $(4), $(8), $(8) 12 11 25 23 Balance at end of period $ (726) $ (682) $ (726) $ (682) Total accumulated other comprehensive loss at end of period $ (19,006) $ (34,486) $ (19,006) $ (34,486) (1) Amounts reclassified to the Vasconia investment carrying value as a result of the discontinuation of the equity method investment of accounting and subsequently recognized as a loss on equity securities in the unaudited condensed consolidated statements of operations, to reduce the Vasconia investment to its fair value. Refer to NOTE 4 —INVESTMENT for additional information. (2) Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations. (3) Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations. |
BASIS OF PRESENTATION AND SUM_4
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Dec. 31, 2023 | Jun. 30, 2023 | Dec. 31, 2022 | |
Schedule Of Significant Accounting Policies [Line Items] | ||||||
Percentage of total annual net sales in the third and fourth quarters | 57% | 54% | ||||
Restructuring expenses | $ 0 | $ 0 | $ 0 | $ 856 | ||
Trade names(1) | ||||||
Schedule Of Significant Accounting Policies [Line Items] | ||||||
Goodwill, percentage of fair value in excess of carrying value | 7% | 7% | ||||
U.S. | ||||||
Schedule Of Significant Accounting Policies [Line Items] | ||||||
Goodwill, percentage of fair value in excess of carrying value | 4% | 4% | ||||
Unallocated [Member] | Employee Severance | ||||||
Schedule Of Significant Accounting Policies [Line Items] | ||||||
Restructuring expenses | $ 800 | |||||
Receivables Purchase Agreement | ||||||
Schedule Of Significant Accounting Policies [Line Items] | ||||||
Receivables available for sale | $ 18,700 | $ 18,700 |
BASIS OF PRESENTATION AND SUM_5
BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Components of Inventory (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Accounting Policies [Abstract] | ||
Finished goods | $ 198,776 | $ 180,860 |
Work in process | 28 | 106 |
Raw materials | 9,676 | 7,681 |
Total | $ 208,480 | $ 188,647 |
REVENUE - Additional Informatio
REVENUE - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 141,666 | $ 146,436 | $ 283,908 | $ 291,871 |
Shipping and Handling | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 600 | $ 500 | $ 1,200 | $ 900 |
REVENUE - Summary of Company's
REVENUE - Summary of Company's Revenue Disaggregated by Geographic Region and Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 141,666 | $ 146,436 | $ 283,908 | $ 291,871 |
United States | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 118,954 | 127,295 | 239,457 | 254,541 |
United Kingdom | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 7,150 | 7,679 | 14,616 | 16,291 |
Rest of World | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 15,562 | 11,462 | 29,835 | 21,039 |
U.S. segment | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 130,503 | 134,979 | 260,983 | 268,464 |
U.S. segment | Kitchenware | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 80,787 | 84,015 | 164,317 | 169,747 |
U.S. segment | Tableware | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 26,341 | 26,149 | 52,100 | 50,148 |
U.S. segment | Home Solutions | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | 23,375 | 24,815 | 44,566 | 48,569 |
International segment | ||||
Disaggregation of Revenue [Line Items] | ||||
Net sales | $ 11,163 | $ 11,457 | $ 22,925 | $ 23,407 |
LEASES - Lease Cost (Details)
LEASES - Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Operating lease expenses: | ||||
Fixed lease expense | $ 4,265 | $ 4,232 | $ 8,528 | $ 8,406 |
Variable lease expense | 1,650 | 1,324 | 3,018 | 2,750 |
Total | $ 5,915 | $ 5,556 | $ 11,546 | $ 11,156 |
LEASES - Supplemental Cash Flow
LEASES - Supplemental Cash Flow Information Related To Leases (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Cash paid for amounts included in the measurement of lease liabilities: | ||
Operating cash flows for operating leases | $ 9,493 | $ 9,661 |
Right-of-use assets obtained in exchange for lease obligations: | ||
Operating leases | $ 423 | $ 2,715 |
LEASES - Maturities of Operatin
LEASES - Maturities of Operating Lease Liability (Details) $ in Thousands | Jun. 30, 2024 USD ($) |
Leases [Abstract] | |
2024 (excluding the six months ended June 30, 2024) | $ 9,536 |
2025 | 18,888 |
2026 | 18,511 |
2027 | 14,290 |
2028 | 12,830 |
2029 | 6,682 |
Thereafter | 11,762 |
Total lease payments | 92,499 |
Less: Interest | (15,046) |
Present value of lease payments | $ 77,453 |
LEASES - Average Lease Terms An
LEASES - Average Lease Terms And Discount Rates (Details) | Jun. 30, 2024 |
Leases [Abstract] | |
Operating lease, weighted average remaining lease term (in years) | 5 years 7 months 6 days |
Operating lease, weighted average discount rate, percent | 6.40% |
INVESTMENTS - Additional Inform
INVESTMENTS - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Schedule of Equity Method Investments [Line Items] | ||||
Loss on equity securities | $ (14,152) | $ 0 | $ (14,152) | $ 0 |
Grupo Vasconia S.A.B. | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage | 24.70% | 24.70% | ||
Loss on equity securities | $ 14,200 |
INVESTMENTS - Summarized Equity
INVESTMENTS - Summarized Equity in Earnings, Net of Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Schedule of Equity Method Investments [Line Items] | ||||
Equity in losses, net of taxes | $ 0 | $ (5,863) | $ (2,092) | $ (8,640) |
Grupo Vasconia S.A.B. | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Equity in losses, net of taxes | 0 | (1,422) | (2,092) | (2,146) |
Equity Investment Impairment Charge | $ 0 | $ (4,441) | $ 0 | $ (6,494) |
INTANGIBLE ASSETS - Components
INTANGIBLE ASSETS - Components of Intangible Assets (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Schedule of Intangible Assets Disclosure [Line Items] | ||
Goodwill, Gross | $ 33,237 | $ 33,237 |
Goodwill | 33,237 | 33,237 |
Finite-lived intangible assets, Accumulated Amortization | (110,966) | (103,474) |
Total, Gross | 302,590 | 302,607 |
Total, Net | 191,624 | 199,133 |
Goodwill, Impaired, Accumulated Impairment Loss | (91,700) | |
Indefinite-lived Intangible Assets, impaired, accumulated impairment loss, | 1,000 | |
Finite-lived Intangible Assets Reduction of Impairment, Gross | 44,100 | |
Finite-lived Intangible Assets reduction for Impairment, Accumulated Amortization | (29,300) | |
Accumulated Impairment Of Intangible Assets, Finite Lived | (14,800) | |
Finite-lived Intangible Assets Reduction for Impairment of U.S. Segment, Gross | 6,500 | |
Licenses | ||
Schedule of Intangible Assets Disclosure [Line Items] | ||
Finite-lived intangible assets, Gross | 15,847 | 15,847 |
Finite-lived intangible assets, Accumulated Amortization | (12,337) | (12,110) |
Finite-lived intangible assets, Net | 3,510 | 3,737 |
Trade names(1) | ||
Schedule of Intangible Assets Disclosure [Line Items] | ||
Finite-lived intangible assets, Gross | 62,478 | 62,493 |
Finite-lived intangible assets, Accumulated Amortization | (25,926) | (23,862) |
Finite-lived intangible assets, Net | 36,552 | 38,631 |
Customer relationships(2) | ||
Schedule of Intangible Assets Disclosure [Line Items] | ||
Finite-lived intangible assets, Gross | 143,157 | 143,158 |
Finite-lived intangible assets, Accumulated Amortization | (68,585) | (63,630) |
Finite-lived intangible assets, Net | 74,572 | 79,528 |
Other (2) | ||
Schedule of Intangible Assets Disclosure [Line Items] | ||
Finite-lived intangible assets, Gross | 5,871 | 5,872 |
Finite-lived intangible assets, Accumulated Amortization | (4,118) | (3,872) |
Finite-lived intangible assets, Net | 1,753 | 2,000 |
Trade names(1) | ||
Schedule of Intangible Assets Disclosure [Line Items] | ||
Indefinite-lived intangible assets, Gross | 42,000 | 42,000 |
Indefinite-lived intangible assets, Net | $ 42,000 | $ 42,000 |
DEBT - Additional Information (
DEBT - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Jun. 08, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Debt Instrument [Line Items] | ||||||
Quarterly payments, percentage of principal amount | 1.25% | |||||
Maximum debt instrument leverage ratio | 3.25 | |||||
line of credit facility, maximum borrowing capacity, limited by covenant | $ 97,200,000 | $ 97,200,000 | ||||
Gain on extinguishments of debt, net | 0 | $ 1,520,000 | ||||
Term Loan | ||||||
Debt Instrument [Line Items] | ||||||
Fees and Expenses | $ 400,000 | |||||
Gain on extinguishments of debt, net | 0 | $ 1,520,000 | 0 | $ (1,520,000) | ||
Extended Term Loan [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, face amount | 150,000,000 | 150,000,000 | ||||
ABL Credit Agreement | ||||||
Debt Instrument [Line Items] | ||||||
Maximum aggregate principal allowed | $ 176,700,000 | 176,700,000 | $ 181,919,000 | |||
Minimum availability under revolving credit to maintain minimum fixed charge ratio for four consecutive months | $ 20,000,000 | |||||
Commitment fee percentage | 10% | |||||
Maximum fixed charge coverage ratio | 1.10 | 1.10 | ||||
Debt Agreements | ||||||
Debt Instrument [Line Items] | ||||||
Percentage of capital stock of foreign subsidiaries pledged as collateral | 65% | 65% | ||||
Minimum term under revolving credit to maintain minimum fixed charge ratio | 45 days | |||||
Term Loan | ||||||
Debt Instrument [Line Items] | ||||||
Debt Instrument, Covenant, Maximum Total Net Leverage Ratio | 5 | |||||
Interest rates on outstanding borrowings | 10.94% | 10.94% | ||||
Debt Instrument, Repurchased Face Amount | 47,200,000 | |||||
Price of the Repurchase for Principal | 95 | |||||
Principal | 100 | |||||
Deferred Debt Issuance Cost, Writeoff | $ 500,000 | |||||
Term Loan | Federal Funds And Overnight Bank Funding Based Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 0.50% | |||||
Term Loan | Alternate Base Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 4.50% | |||||
Term Loan | One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR") | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 1% | |||||
Term Loan | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 5.50% | |||||
Minimum | Term Loan | One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR") | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, stated rate | 1% | 1% | ||||
Minimum | Term Loan | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, stated rate | 1% | 1% | ||||
Senior Secured Asset Based Revolving Credit Facilities | ABL Credit Agreement | ||||||
Debt Instrument [Line Items] | ||||||
Maximum aggregate principal allowed | $ 200,000,000 | $ 200,000,000 | ||||
Increase in maximum borrowing capacity | 250,000,000 | 250,000,000 | ||||
Debt instrument, stated amount | $ 50,000,000 | $ 50,000,000 | ||||
Revolving Credit Facility | ABL Credit Agreement | ||||||
Debt Instrument [Line Items] | ||||||
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Paid | 0.25% | |||||
Revolving Credit Facility | ABL Credit Agreement | Federal Funds And Overnight Bank Funding Based Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 0.50% | |||||
Revolving Credit Facility | ABL Credit Agreement | One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR") | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, stated rate | 1% | 1% | ||||
Revolving Credit Facility | ABL Credit Agreement | 1, 3 or 6 month interest period | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, stated rate | 0.10% | 0.10% | ||||
Revolving Credit Facility | Minimum | ABL Credit Agreement | ||||||
Debt Instrument [Line Items] | ||||||
Commitment fee percentage | 0.20% | |||||
Revolving Credit Facility | Minimum | ABL Credit Agreement | Alternate Base Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 0.25% | |||||
Revolving Credit Facility | Minimum | ABL Credit Agreement | One Month Adjusted Term SEcured Overnight Financing Rate ("SOFR") | ||||||
Debt Instrument [Line Items] | ||||||
Debt instrument, stated rate | 1% | 1% | ||||
Revolving Credit Facility | Minimum | ABL Credit Agreement | Adjusted Term SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 1.25% | |||||
Revolving Credit Facility | Minimum | ABL Credit Agreement | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest rates on outstanding borrowings | 4.91% | 4.91% | ||||
Revolving Credit Facility | Maximum | ABL Credit Agreement | ||||||
Debt Instrument [Line Items] | ||||||
Commitment fee percentage | 0.25% | |||||
Revolving Credit Facility | Maximum | ABL Credit Agreement | Alternate Base Rate | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 0.50% | |||||
Revolving Credit Facility | Maximum | ABL Credit Agreement | Adjusted Term SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Basis spread on variable rate | 1.50% | |||||
Revolving Credit Facility | Maximum | ABL Credit Agreement | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest rates on outstanding borrowings | 8.75% | 8.75% |
DEBT - Total Availability Under
DEBT - Total Availability Under ABL Agreement (Details) - ABL Credit Agreement - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Debt Instrument [Line Items] | ||
Maximum aggregate principal allowed | $ 176,700 | $ 181,919 |
Line of Credit, Current | (32,635) | (60,395) |
Standby letters of credit | (8,534) | (2,894) |
Total availability under the ABL Agreement | $ 135,531 | $ 118,630 |
DEBT - Schedule of Term Loan Fa
DEBT - Schedule of Term Loan Facility (Details) - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Debt Instrument [Line Items] | ||
Total Current portion of Term Loan facility | $ 6,822 | $ 4,742 |
Term Loan | ||
Debt Instrument [Line Items] | ||
Term Loan payment | 7,500 | 7,500 |
Estimated Excess Cash Flow principal payment | 2,000 | 0 |
Estimated unamortized debt issuance costs | (2,678) | (2,758) |
Total Current portion of Term Loan facility | 6,822 | 4,742 |
Total Non Current portion of Term Loan facility | 138,625 | 142,500 |
Estimated unamortized debt issuance costs | (5,347) | (6,666) |
Total Non-current portion of Term Loan | $ 133,278 | $ 135,834 |
DERIVATIVES - Additional Inform
DERIVATIVES - Additional Information (Details) - USD ($) | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Mar. 13, 2024 | Jun. 11, 2019 | |
Derivative [Line Items] | ||||||
Gain (loss) reclassified into earnings | $ (20,000) | $ 40,000 | $ (200,000) | $ 900,000 | ||
Loss to be reclassified within 12 months | 100,000 | |||||
Interest rate swaps | ||||||
Derivative [Line Items] | ||||||
Notional amount | 50,000,000 | 25,000,000 | 50,000,000 | 25,000,000 | ||
Derivatives designated as hedging instruments | Foreign exchange contracts | ||||||
Derivative [Line Items] | ||||||
Notional amount | 5,200,000 | 5,200,000 | ||||
Derivatives designated as hedging instruments | Cash Flow Hedging | Interest rate swaps | ||||||
Derivative [Line Items] | ||||||
Notional amount | $ 0 | $ 0 | ||||
Derivatives not designated as hedging instruments | Interest rate swaps | ||||||
Derivative [Line Items] | ||||||
Notional amount | $ 25,000,000 | $ 25,000,000 | ||||
Interest expense | Interest rate swaps | ||||||
Derivative [Line Items] | ||||||
Gain (loss) reclassified into earnings | 100,000 | |||||
Cost of Sales | Foreign exchange contracts | ||||||
Derivative [Line Items] | ||||||
Gain (loss) reclassified into earnings | $ 40,000 | $ 800,000 |
DERIVATIVES - Fair Values of De
DERIVATIVES - Fair Values of Derivative Financial Instruments Included in Consolidated Balance Sheets (Details) - Fair Value, Observable inputs, Level 2 - USD ($) $ in Thousands | Jun. 30, 2024 | Dec. 31, 2023 |
Prepaid expenses and other current assets | Foreign exchange contracts | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Fair value of derivative assets | $ 44 | $ 56 |
Prepaid expenses and other current assets | Interest rate swaps | Derivatives not designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Fair value of derivative assets | 553 | 0 |
Accrued expenses | Foreign exchange contracts | Derivatives designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Fair value of derivative assets | 53 | 144 |
Other Noncurrent Assets | Interest rate swaps | Derivatives not designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Fair value of derivative assets | 0 | 793 |
Other long-term liabilities | Interest rate swaps | Derivatives not designated as hedging instruments | ||
Derivatives, Fair Value [Line Items] | ||
Fair value of derivative liability | $ 16 | $ 0 |
DERIVATIVES - Gains and Losses
DERIVATIVES - Gains and Losses Related to Derivative Financial Instruments Designated as Hedging Instruments (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Net change in cash flow hedges | $ 22 | $ (300) | $ 223 | $ (1,453) |
Interest rate swaps | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Net change in cash flow hedges | 0 | 0 | 0 | (120) |
Foreign exchange contracts | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Net change in cash flow hedges | $ 22 | $ (300) | $ 223 | $ (1,333) |
DERIVATIVES - Gains and Losse_2
DERIVATIVES - Gains and Losses Related to Derivative Financial Instruments Not Designated as Hedging Instruments (Details) - Interest rate swaps - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains (losses) on derivative financial instruments not designated as hedging instruments | $ 227 | $ 393 | $ 274 | $ 324 |
Mark to market (loss) gain on interest rate derivatives | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains (losses) on derivative financial instruments not designated as hedging instruments | (82) | 197 | (256) | (37) |
Interest expense | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gains (losses) on derivative financial instruments not designated as hedging instruments | $ 309 | $ 196 | $ 530 | $ 361 |
STOCK COMPENSATION - Summary of
STOCK COMPENSATION - Summary of Stock Option (Details) $ / shares in Units, $ in Thousands | 6 Months Ended |
Jun. 30, 2024 USD ($) $ / shares shares | |
Options | |
Beginning balance (in shares) | shares | 999,500 |
Grants (in shares) | shares | 50,000 |
Expirations (in shares) | shares | (252,000) |
Ending balance (in shares) | shares | 797,500 |
Options exercisable, end of period (in shares) | shares | 674,500 |
Weighted- average exercise price | |
Beginning balance (usd per share) | $ / shares | $ 13.31 |
Grants (usd per share) | $ / shares | 9.76 |
Expirations (usd per share) | $ / shares | 18.68 |
Ending balance (usd per share) | $ / shares | 11.40 |
Weighted-average exercise price, Options exercisable, end of period (usd per share) | $ / shares | $ 11.78 |
Weighted- average remaining contractual life (years) | |
Options outstanding, end of period | 5 years 2 months 12 days |
Options exercisable, end of period | 4 years 6 months |
Aggregate intrinsic value (in thousands) | |
Options outstanding, aggregate intrinsic Value | $ | $ 197 |
Options exercisable, aggregate intrinsic Value | $ | 97 |
Total unrecognized stock option expense remaining (in thousands) | $ | $ 495 |
Weighted-average years expected to be recognized over (in years) | 1 year 9 months 18 days |
STOCK COMPENSATION - Summary _2
STOCK COMPENSATION - Summary of Restricted Stock Activity (Details) $ / shares in Units, $ in Thousands | 6 Months Ended |
Jun. 30, 2024 USD ($) $ / shares shares | |
Restricted Shares | |
Weighted-average years expected to be recognized over (in years) | 1 year 9 months 18 days |
Restricted Stock | |
Restricted Shares | |
Beginning balance (in shares) | shares | 597,528 |
Grants (in shares) | shares | 313,199 |
Vested (in shares) | shares | (306,425) |
Cancellations (in shares) | shares | (8,599) |
Ending balance (in shares) | shares | 595,703 |
Total unrecognized compensation expense remaining (in thousands) | $ | $ 4,976 |
Weighted-average years expected to be recognized over (in years) | 1 year 8 months 12 days |
Weighted- average grant date fair value | |
Beginning balance (usd per share) | $ / shares | $ 8.44 |
Grants (usd per share) | $ / shares | 9.54 |
Vested (usd per share) | $ / shares | 7.53 |
Cancellations (usd per share) | $ / shares | 10.07 |
Ending balance (usd per share) | $ / shares | $ 9.46 |
STOCK COMPENSATION - Additional
STOCK COMPENSATION - Additional Information (Details) - USD ($) $ in Millions | 6 Months Ended | |
Jun. 20, 2024 | Jun. 30, 2024 | |
Restricted Stock | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Fair value of equity instruments | $ 2.8 | |
Performance Shares | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Fair value of equity instruments | $ 1.5 | |
Number of shares range percentage | 150% | |
Performance Shares | Amended and Restated Long Term Incentive Plan Two Thousand | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 1,500,000 | |
Number of shares available for grant (in shares) | 1,804,161 | |
Cash Settled Performance Based Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Number of shares range percentage | 150% |
STOCK COMPENSATION - Summary _3
STOCK COMPENSATION - Summary of Performance-based Award Activity (Details) $ / shares in Units, $ in Thousands | 6 Months Ended |
Jun. 30, 2024 USD ($) $ / shares shares | |
Restricted Shares | |
Weighted-average years expected to be recognized over (in years) | 1 year 9 months 18 days |
Performance Shares | |
Restricted Shares | |
Beginning balance (in shares) | shares | 486,972 |
Grants (in shares) | shares | 219,975 |
Vested (in shares) | shares | (152,188) |
Cancellations (in shares) | shares | (23,815) |
Ending balance (in shares) | shares | 530,944 |
Total unrecognized compensation expense remaining (in thousands) | $ | $ 2,437 |
Weighted-average years expected to be recognized over (in years) | 2 years 3 months 18 days |
Weighted- average grant date fair value | |
Beginning balance (usd per share) | $ / shares | $ 10.44 |
Grants (usd per share) | $ / shares | 9.76 |
Vested (usd per share) | $ / shares | 14.18 |
Cancellations (usd per share) | $ / shares | 13.35 |
Ending balance (usd per share) | $ / shares | $ 8.96 |
STOCK COMPENSATION - Stock Comp
STOCK COMPENSATION - Stock Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Stock compensation expense | $ 1,037 | $ 1,011 | $ 1,844 | $ 1,872 |
Equity based stock option expense | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Stock compensation expense | 60 | 50 | 110 | 179 |
Restricted and performance-based stock awards expense | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Stock compensation expense | 984 | 960 | 1,733 | 1,697 |
Equity based awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Stock compensation expense | 1,044 | 1,010 | 1,843 | 1,876 |
Liability based stock option expense | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | ||||
Stock compensation expense | $ (7) | $ 1 | $ 1 | $ (4) |
STOCK COMPENSATION (Details)
STOCK COMPENSATION (Details) - USD ($) $ / shares in Units, $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Dec. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average years expected to be recognized over (in years) | 1 year 9 months 18 days | |
Cash Settled Performance Based Awards | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Liability Instruments Other Than Options, Forfeited in Period | (1,269) | |
Share-based Compensation Arrangement by Share-based Payment Award, Liability Instruments Other than Options, Forfeiteds in Period, Weighted Average Grant Date Fair Value | $ 8.44 | |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | 82,342 | 83,611 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ 8.59 | $ 6.71 |
Total unrecognized compensation expense remaining (in thousands) | $ 0 | |
Weighted-average years expected to be recognized over (in years) | 0 years | |
Performance Shares | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total unrecognized compensation expense remaining (in thousands) | $ 2,437 | |
Weighted-average years expected to be recognized over (in years) | 2 years 3 months 18 days |
INCOME (LOSS) PER COMMON SHAR_2
INCOME (LOSS) PER COMMON SHARE - Calculations of Basic and Diluted Loss per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items] | ||||||
Net loss | $ (18,167) | $ (6,260) | $ (6,520) | $ (8,805) | $ (24,427) | $ (15,325) |
Weighted-average shares outstanding - Basic (in shares) | 21,421 | 21,123 | 21,399 | 21,174 | ||
Effect of dilutive securities: | ||||||
Weighted-average shares outstanding - diluted (in shares) | 21,421 | 21,123 | 21,399 | 21,174 | ||
Basic income (loss) per common share (usd per share) | $ (0.85) | $ (0.31) | $ (1.14) | $ (0.72) | ||
Diluted income (loss) per common share (usd per share) | $ (0.85) | $ (0.31) | $ (1.14) | $ (0.72) | ||
Antidilutive securities (in shares) | 1,507 | 1,624 | 1,556 | 1,603 | ||
Stock options and other stock awards | ||||||
Effect of dilutive securities: | ||||||
Stock options and other stock awards (in shares) | 0 | 0 | 0 | 0 |
INCOME TAXES - Additional Infor
INCOME TAXES - Additional Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |
Income Tax Disclosure [Abstract] | ||||
Income tax benefit (provision) | $ 57 | $ (1,242) | $ (153) | $ 106 |
Effective income tax benefit rate on US and foreign earnings, percent | 0.30% | 212.30% | (0.70%) | 1.60% |
Corporate income tax rate | 21% | 21% | 21% | 21% |
BUSINESS SEGMENTS - Additional
BUSINESS SEGMENTS - Additional Information (Details) | 6 Months Ended |
Jun. 30, 2024 segment | |
Segment Reporting [Abstract] | |
Number of reportable business segment | 2 |
BUSINESS SEGMENTS - Segment Rep
BUSINESS SEGMENTS - Segment Reporting Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | |||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Dec. 31, 2023 | |
Segment Reporting Information [Line Items] | |||||
Net sales | $ 141,666 | $ 146,436 | $ 283,908 | $ 291,871 | |
Income from operations | 1,167 | 4,396 | 2,997 | 2,590 | |
Depreciation and amortization | 4,894 | 4,925 | 9,833 | 9,795 | |
Assets | 616,964 | 616,964 | $ 667,142 | ||
U.S. | |||||
Segment Reporting Information [Line Items] | |||||
Net sales | 118,954 | 127,295 | 239,457 | 254,541 | |
Operating segments | U.S. | |||||
Segment Reporting Information [Line Items] | |||||
Assets | 529,983 | 529,983 | 560,716 | ||
Operating segments | International | |||||
Segment Reporting Information [Line Items] | |||||
Assets | 80,039 | 80,039 | 90,237 | ||
Unallocated corporate expenses | |||||
Segment Reporting Information [Line Items] | |||||
Income from operations | (5,090) | (4,511) | (9,613) | (10,379) | |
Assets | 6,942 | 6,942 | $ 16,189 | ||
U.S. | Operating segments | |||||
Segment Reporting Information [Line Items] | |||||
Net sales | 130,503 | 134,979 | 260,983 | 268,464 | |
Income from operations | 9,189 | 11,736 | 18,631 | 17,690 | |
Depreciation and amortization | 4,612 | 4,646 | 9,268 | 9,264 | |
International | Operating segments | |||||
Segment Reporting Information [Line Items] | |||||
Net sales | 11,163 | 11,457 | 22,925 | 23,407 | |
Income from operations | (2,932) | (2,829) | (6,021) | (4,721) | |
Depreciation and amortization | $ 282 | $ 279 | $ 565 | $ 531 |
CONTINGENCIES - Additional Info
CONTINGENCIES - Additional Information (Details) $ in Millions | 6 Months Ended | |||
Jun. 30, 2024 USD ($) tablewareCollection | Jun. 30, 2024 USD ($) tablewareCollection | Oct. 15, 2020 protest | Jun. 08, 2020 protest | |
Commitments and Contingencies Disclosure [Line Items] | ||||
Site Contingency, Environmental Remediation Costs Recognized | 5.6 million | |||
Number of tableware collections | tablewareCollection | 7 | |||
Number of protests filed | protest | 3 | |||
Number of remaining tableware collections | tablewareCollection | 29 | |||
Number of protests approved | protest | 1 | |||
Number of protests pending | tablewareCollection | 2 | 2 | ||
Period of investigation | 5 years | |||
Estimated Duties That Could Be Owed | ||||
Commitments and Contingencies Disclosure [Line Items] | ||||
Reasonable possible loss | $ 0.1 | $ 0.1 | ||
Negligence | ||||
Commitments and Contingencies Disclosure [Line Items] | ||||
Reasonable possible loss | 0.3 | 0.3 | ||
Gross Negligence | ||||
Commitments and Contingencies Disclosure [Line Items] | ||||
Reasonable possible loss | $ 0.6 | 0.6 | ||
Capital cost | San German Ground Water Contamination Site, Initial Operable Unit | ||||
Commitments and Contingencies Disclosure [Line Items] | ||||
Remedial alternative, EPA preferred remedy | 7.3 | |||
Capital cost | San German Ground Water Contamination Site, Second Operable Unit | ||||
Commitments and Contingencies Disclosure [Line Items] | ||||
Remedial alternative, EPA preferred remedy | $ 17.3 |
OTHER - Cash Dividends Declared
OTHER - Cash Dividends Declared (Details) - $ / shares | 6 Months Ended | |||
Jun. 20, 2024 | Mar. 08, 2024 | Jun. 30, 2024 | Jun. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Dividend per share of common stock (usd per share) | $ 0.0425 | $ 0.0425 | $ 0.085 | $ 0.085 |
OTHER - Additional Information
OTHER - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 6 Months Ended | |||||||||||
Aug. 06, 2024 | Jun. 20, 2024 | May 15, 2024 | Mar. 08, 2024 | Feb. 15, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Jun. 30, 2023 | Mar. 31, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | Mar. 14, 2022 | Apr. 30, 2013 | |
Other [Line Items] | |||||||||||||
Cash dividends paid | $ 1,977 | $ 1,907 | |||||||||||
Cash dividend paid upon vesting of restricted shares and performance shares | $ 200 | ||||||||||||
Dividends accrued | $ 957 | $ 943 | $ 950 | $ 930 | |||||||||
Dividend per share, declared (usd per share) | $ 0.0425 | $ 0.0425 | $ 0.085 | $ 0.085 | |||||||||
Stock Repurchase Program, Authorized Amount | $ 20,000 | $ 10,000 | |||||||||||
Stock Repurchase Program, Remaining Authorized Repurchase Amount | 11,100 | $ 11,100 | |||||||||||
Subsequent Event | |||||||||||||
Other [Line Items] | |||||||||||||
Dividend per share, declared (usd per share) | $ 0.0425 | ||||||||||||
Retained earnings (accumulated deficit) | |||||||||||||
Other [Line Items] | |||||||||||||
Dividends accrued | $ 957 | $ 943 | $ 950 | $ 930 | |||||||||
Dividend Paid | |||||||||||||
Other [Line Items] | |||||||||||||
Cash dividends paid | $ 900 | $ 900 | $ 2,000 |
OTHER - Supplemental Cash Flow
OTHER - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 6 Months Ended | |
Jun. 30, 2024 | Jun. 30, 2023 | |
Supplemental disclosure of cash flow information: | ||
Cash paid for interest | $ 9,853 | $ 10,453 |
Cash paid for taxes, net of refunds | $ 4,193 | $ 3,188 |
OTHER - Components of Accumulat
OTHER - Components of Accumulated Other Comprehensive Loss, Net (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||||
Jun. 30, 2024 | Jun. 30, 2023 | Jun. 30, 2024 | Jun. 30, 2023 | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||
Balance at beginning of year | $ 223,701 | $ 228,661 | [1] | $ 230,879 | $ 240,088 | |
Balance at end of year | 219,805 | (223,051) | [1] | 219,805 | (223,051) | [1] |
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax | (4) | (4) | (8) | (8) | ||
Accumulated translation adjustment: | ||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||
Balance at beginning of year | (32,574) | (34,511) | (32,614) | (36,072) | ||
Other comprehensive income, before reclassifications | 53 | 1,237 | 93 | 2,798 | ||
Amounts reclassified from accumulated other comprehensive loss | 14,152 | 0 | 14,152 | 0 | ||
Other comprehensive income (loss), net of taxes | 14,205 | 1,237 | 14,245 | 2,798 | ||
Balance at end of year | (18,369) | (33,274) | (18,369) | (33,274) | ||
Accumulated deferred gains (losses) on cash flow hedges: | ||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||
Balance at beginning of year | 67 | (230) | (134) | 923 | ||
Other comprehensive income, before reclassifications | 2 | (261) | 72 | (511) | ||
Amounts reclassified from accumulated other comprehensive loss | 20 | (39) | 151 | (942) | ||
Other comprehensive income (loss), net of taxes | 22 | (300) | 223 | (1,453) | ||
Balance at end of year | 89 | (530) | 89 | (530) | ||
Income tax expense (benefit) | 0 | 0 | 0 | (2) | ||
Accumulated effect of retirement benefit obligations: | ||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||
Balance at beginning of year | (738) | (693) | (751) | (705) | ||
Amounts reclassified from accumulated other comprehensive loss | 12 | 11 | 25 | 23 | ||
Balance at end of year | (726) | (682) | (726) | (682) | ||
Accumulated other comprehensive loss | ||||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||||
Balance at beginning of year | (33,245) | (35,434) | (33,499) | (35,854) | ||
Balance at end of year | $ (19,006) | $ (34,486) | $ (19,006) | $ (34,486) | ||
[1] Cash dividends declared per share of common stock were $0.085 and $0.085 in the six months ended June 30, 2024 and 2023, respectively. |